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Zanvil Alexander Cohn, an editor of this Journal since 1973, died suddenly on June 28,
1993. Cohn is best known as the father of the current era of macrophage biology. Many
of his scientific accomplishments are recounted here, beginning with seminal studies on
the granules of phagocytes that were performed with his close colleague and former editor
of thisJournaI, James Hirsch. Cohn and Hirsch identified the granules as lysosomes that
discharged their contents of digestive enzymes into vacuoles containing phagocytosed
microbes. These findings were part of the formative era of cell biology and initiated the
modern study of endocytosis and cell-mediated resistance to infection. Cohn further explored the endocytic apparatus in pioneering studies of the mouse peritoneal macrophage
in culture. He described vesicular inputs from the cell surface and Golgi apparatus and
documented the thoroughness of substrate digestion within lysosomal vacuoles that would
only permit the egress of monosaccharides and amino acids. These discoveries created
a vigorous environment for graduate students, postdoctoral fellows, and junior and visiting
faculty. Some of the major findings that emerged from Cohn's collaborations included
the radioiodination of the plasma membrane for studies of composition and turnover;
membrane recycling during endocytosis; the origin of the mononuclear phagocyte system
in situ; the discovery of the dendritic cell system of antigen-presenting cells; the macrophage as a secretory cell, including the release of proteases and large amounts of
prostaglandins and leukotrienes; several defined parameters of macrophage activation,
especially the ability of T cell-derived lymphokines to enhance killing of tumor cells
and intracellular protozoa; the granule discharge mechanism whereby cytotoxic lymphocytes release the pore-forming protein perforin; the signaling of macrophages via myristoylated substrates of protein kinase C; and a tissue culture model in which monocytes emigrate across tight endothelial junctions. In 1983, Cohn turned to a long-standing goal
of exploring host resistance directly in humans. He studied leprosy, focusing on the disease site, the parasitized macrophages of the skin. He injected recombinant lymphokines
into the skin and found that these molecules elicited several cell-mediated responses. Seeing
this potential to enhance host defense in patients, Cohn was extending his clinical studies
to AIDS and tuberculosis. Zanvil Cohn was a consummate physician-scientist who nurtured the relationship between cell biology and infectious disease. He guided with a warm
but incisive manner the careers of many individuals. He was deeply committed to several
institutions of biomedical research; to medicine in the developing world; to The Rockefeller University, especially its programs for graduate study and patient-oriented research;
and to the energy and spirit of this Journal.

A THbute

Zanvil Alexander Cohn, 1926-1993

his is the first volume since 1973 for which Zanvil
T
Cohn has not served as an editor of The Journal of Experimental Medicine. Zan died suddenly on June 28, 1993. He

Recruitment to Infectious Diseases
and to Phagocytes
A devotion to infectious diseases came quickly to Zan at
Harvard Medical School. Prior to starting the curriculum,
he spent a year in the Department of Microbiology. He then
continued to do independent laboratory work and produced
a thesis entitled "A Biochemical Study of the Interaction of
the Influenza A Virus and the Chorioallantoic Membrane of
the Hefts Egg" The work was supervised by Monroe D. Eaton
and Boris Magasanik, and led to his first publication (1). In
the introduction to his thesis, Zan announced what would
be a life-long scientific interest, the host-parasite relationship. Zafts M.D. degree in 1953 was one of a very few to
be awarded summa cure laude in the history of Harvard Medical School.
Zan trained in medicine from 1953 to 1955 at the Massachusetts General Hospital. From 1955 to 1957, he met his
military obligations, rising to Chief of the Division of Rickettsial Biology, Walter Reed Army Institute, and Captain in
the Army Medical Corps. In the laboratory of Joseph Smadel,
Zan explored several topics with rickettsiae that were prescient of his subsequent work (2-5, 8), with emphasis on
respiratory enzymes, the microbial cell wall, and the penetration of Rickettsia tsutsugamushi into a mammalian cell line
in vitro (5). The latter was the first of Zan's 128 contributions to the Journal.
Either in medical school or during his postgraduate training,
Zan developed his intense admiration of Ren~ Dubos of The
Rockefeller Institute for Medical Research. Dubos was an
eminent microbiologist who emphasized the host-parasite
interplay, the microenvironment of inflammation, and the
need for new therapies that would enhance host defense. Zan
heard Dubos's Warren Triennial Lecture at Massachusetts
General in 1953, which was incorporated in his monograph

University Press). After the lecture, Zan approached Dubos
for a position at the Rockefeller. This was eventually granted,
although Dubos urged Zan not to work on viruses!
In 1957, Zanjoined Dubos's laboratory, which was affiliated
with The Rockefeller Hospital. James Hirsch was part of the
team and was fully engaged in studies of phagocytes in vitro.
In 1960, Hirsch became professor and organized a new Laboratory of Cellular Immunology. Zan, Stephen Morse, and Louis
Siltzbach were the first members of the new lab. Cohn participated in the lab's clinical studies in the Hospital on sarcoidosis (14, 15, 44) that standardized the use of the Kveim
reagent in the diagnosis of this disease.
Dubos and Hirsch, themselves former editors of thisJournal,
must have had a substantial influence on Zafts style. All three
had a similar dedication to the broad reaches of the host-parasite interplay. All three coupled a seriousness of scientific purpose and a high regard for experimentation with an affable
and sometimes skeptical manner. All three had a real optimism tempered by a respect for the unknown.
Zan began his studies of the phagocyte-microbe interaction with Morse (6, 9, 10). They utilized Hirsch's methods
for obtaining homogeneous populations of neutrophils in large
numbers, especially glycogen-elicited, rabbit peritoneal exudates. Cohn and Morse adapted methods of Ole Maalce to
segregate the two phases of white cell resistance, ingestion
and killing. Neither phase was readily amenable to analysis
in vivo since the white cell populations were mixed, blood
and tissue fluids could have complicating effects, and quantitation was difficult. Cohn and Morse were able to separate
cells from nonbound organisms in vitro and thereby to quantitate ingestion and killing. They observed the three basic
outcomes: phagocytosis with killing (Staphylococcusalbus, Escherichia coli, and certain streptococci), phagocytosis without
killing (Mycobacterium smegmatis), and no phagocytosis at all
(S. aureus and group A streptococci). Glycolysis was critical,
as were serum opsonins in the case orS. aureus. Lipopolysaccharide (LPS) or endotoxin increased phagocytic activity. The
approach taken by Morse and Cohn, the quantitative and direct study of the phagocyte-microbe interaction in vitro, was
to bear fruit quickly.

Phagocyte Granules Are Lysosomes That
Degranulate and Digest Microbes
Cohn and Hirsch, focusing on events after ingestion, approached the most striking morphologic feature of the poly-
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gave the Journal years of leadership and energy, and his unique
style enlivened our weekly deliberations. His incisive manner,
his admiration of clever new experiments, his sense of fairness and respect, and his wit all will be sorely missed. A review of his scientific contributions and the environment in
which these came about, some feelings about the man, including his love for this Journal, and a complete bibliography
seem a fitting tribute to our friend and colleague.

Biochemical Determinants of Microbial Diseases (1954, Harvard

Figure 1. A representativefieldtakenfrom a sectionedgranulepellet
shows lysosomesenrichedfrom neutrophils, x23,000 (11, Fig. 1).
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Figure 2. Degranulationof polymorphonuclearleukocytesduringphagocytosis.Note the lossof cytoplasmicgranulesin two rabbit whitecells
that haveingestedchainsof streptococci(arrows),and thepresenceofgranules
in a cell that has not phagocytosedorganisms(arrowhead).xl,080 (12,
Fig. 1 c).

Zan took a biochemical approach to extend the concepts
of granules as lysosomes that discharged and digested microbes during phagocytosis. He radiolabeled the nucleic acids
and proteins of bacteria with 32p and 14C, respectively. He
found that ingested organisms first lost their pools of acidsoluble metabolites and, within three hours, 70% of the acidinsoluble constituents were converted to TCA-soluble products (22). Once the organisms were internalized, a variety
of metabolic inhibitors could not slow digestion (23).
Then, with Edith Wiener, a postdoctoral fellow from
Jerusalem, Zan isolated the particulate hydrolases of macrophages (24, 25). To secure an abundant and homogeneous
cell source, Cohn and Wiener elicited rabbit alveolar and peritoneal macrophages with BCG and with mineral oil, respectively. Then they separated the granules ofmacrophages from
the other major organelles, especially mitochondria, on
isopycnic sucrose gradients. They proved that macrophage
granules, like those of their polymorphonuclear cousins, are
a particularly rich source of de Duve's lysosomes. One of Zan's
favorite images was an early electron micrograph of the abundant lysosomes in a BCG-elicited alveolar macrophage (Fig. 3).
When Zan followed the response of macrophage lysosomes
to particle ingestion (25), he again observed a solubilization
of the particulate hydrolases. Zan had the benefit of unpublished electron micrographs from his friend David Luck, who
documented the continuity of the phagolysosomal compartment in macrophages. This was soon followed by the seminal
micrographs of Dorothy Zucker-Franklin, who together with
Hirsch visualized lysosome-phagosome fusion in neutrophils.
So Zan concluded that phagocyte granules were lysosomes
that discharged their contents into the phagosome containing
the ingested organism. The membranes of this phagolysosome, or digestive compartment, were rupturing during cell
homogenization, accounting for the observed solubilization
of hydrolases during phagocytosis.
Zan wrote of these experiments, "once a foreign substance
has been taken into the cytoplasm of the macrophage and
segregated within a membrane system, its fate may depend
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morphonuclear leukocyte, or "poly" the abundant granules.
Three historic papers appeared together in TheJournal of Experimental Medicine (11-13). Using the techniques that were
being pioneered by Albert Claude, Christian de Duve, and
George Palade at The Rockefeller Institute, Zan and Jim were
able to isolate a morphologically homogeneous population
of granules by differential centrifugation (11) (Fig. 1). They
wrote that "the efficient but relatively nontraumatic disruption" of the polys in cold 0.34 M sucrose was key, and they
used the classic combination of high specific activity and
recovery to establish that the granules were the location for
a group of hydrolytic enzymes active at low pH. They showed
that the acid hydrolases exhibited "latency," requiring disruption by freezing and thawing for activity, and they observed the limiting membrane of the granules by electron
microscopy. So the granules of the phagocyte, an object of
tinctorial delight for decades, were now a biochemical and
cell biological entity, identical to the lysosomes described by
de Duve and colleagues.
Hirsch and Cohn next worked out methods that proved
that polys degranulated during phagocytosis (12). By first applying the leukocytes to a surface, and then applying the organisms, they observed that degranulation took place only
in cells that had ingested organisms (Fig. 2). To visualize degranulation more vividly, Hirsch produced elegant films of
live phagocytes. These films, which remain an ideal component for many courses in biology, allowed Zan and Jim to
propose that granule lysis played a key role in the destruction
of microorganisms. Cohn and Hirsch then used cell fractionation to solidify the notion of granule discharge (13). They
found that in phagocytosing populations, a large proportion
of the acid hydrolases moved from a pellet fraction to a soluble
fraction. Later (see below) they realized that this "solubilization" was a manifestation of lysosome-phagosome fusion.

in part upon its susceptibility to macrophage enzymes. Certain inert substances are retained, whereas others are probably degraded in short order. Such storage of material may
be reflected in the accumulation of macrophages at local sites
such as in tuberculous and lepromatous lesions" (25). So the
cell biology of endocytosis and host resistance had begun,
and reciprocally, phagocytes occupied a central place during
the formative years of cell biology. Here the seeds were also
sown that certain organisms might escape digestion, a topic
that Zan was to pursue in the context of leprosy and tuberculosis 20 years later.

The Formation of Lysosomes in Cultured Mouse
Peritoneal Macrophages
Zan then switched from rabbit to mouse phagocytes, a
change that would eventually lead to the use of the cultured
5
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mouse peritoneal macrophage as a model for further pioneering
studies in cell biology. The impetus for this switch most likely
took place during studies described in the YaleJournat of Biology and Medicine in 1962 (16-18). In a characteristically short
introduction, he points out that the intradermal and intravenous routes of infection make it hard to follow the organisms,
that are being injected in vivo. In contrast, he states, the mouse
peritoneal cavity might provide a more suitable milieu to follow
quantitatively both cell-associated and nonassociated organisms, much as he and Morse had done with rabbit phagocytes in vitro. He worked with staphylococci, organisms that
had been studied by Dubos, and verified several features in
vivo. Avirulent S. albus were internalized efficiently, whereas
the lethal S. aureus multiplied extracellularly, avoiding uptake, unless immune serum was added. Phagocyte mobilization or diapedesis was markedly reduced when mice were
treated with cortisone, x rays, and other blockers of host re-
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Figure 3. An electron micrograph of a typicalBCG-inducedalveolarmacrophage that shows abundant lysosomalgranules. Granules of various
size, density,and internalstructureare arrangedin a rosette-likefashionin the perinuclearregion. Theseparticlesvaryfrom a uniformelectrondensity
to multivesiculatedstructures and myelinfigures, x12,000 (24, Fig. 1).

sistance that Dubos had described. Zan emphasized that two
populations of phagocytes were at work, resident macrophages
and recruited polymorphonuclear granulocytes. A major determinant of bacterial destruction was the availability of phagocytes in sufficient numbers.
Seeing that mouse peritoneal cells adhering to glass were
a homogeneous source of competent and abundant phagocytes, Zan turned his full attention to this population. In 1965,
he published four papers with Belinda Benson in TheJournal
of ExperimentalMedicinedescribing the "in vitro differentiation of mononuclear phagocytes" (30-33). As was now standard fare in the laboratory, high quality phase contrast
microscopy spawned and/or supported virtually every experiment. Zan noted that macrophages from different sources
varied enormously in their content of phase-dense granules
and hydrolytic enzymes, and resident peritoneal macrophages
were relatively weak in both respects. Yet he described a huge
increase in phase-dense, perinuclear granules over several days
in culture in glass Leighton tubes. Excellent preservation was
afforded by the glutaraldehyde fixation regime developed by
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Figure 4. The differentiationof mousemacrophagesin culture.A macrophagecultivatedin 50% serummediumfor 48 h. A well-definedcollection of large lysosomalgranulesis present in the periuuclearregion. A
(33,
numberof clearpinocyticvacuolesare alsoapparent(arrows).•
Fig. 1 a).

David Sabatini at Rockefeller (30). Zan distinguished the
granules from rod-like mitochondria (Fig. 4) and stained the
former selectively with acid hydrolase cytochemistry as outlined by Alex Novikoff. During culture of the macrophages,
he also documented a marked increase in acid hydrolase activity. Zan used metabolic precursors and autoradiography
to study the differentiation question (31). He showed that
silver grains from radiolabeled leucine and choline accumulated over the phase dense granules. These precursors and autoradiography were just becoming available in cell biology,
and the methods were being used by Lucien Caro and Palade,
and by Luck, in other Institute labs.
Zan emphasized that serum in the culture medium was
a major and reversible inducer of granule differentiation, and
that serum also stimulated the formation of phase-lucent pinocytic vesicles (32). After their formation at the cell periphery,
the vesicles moved centripetally and gradually acquired the
features of lysosomes, becoming phase dense and acid phosphatase positive. Zan applied exogenous soluble tracers, notably
colloidal gold and fluorescein-modified proteins, to prove that
they would accumulate in the phase-dense granules, or lysosomes (33).
With the arrival of an electron microscope in the lab, Hirsch,
Cohn, and Martha Fedorko provided clear views of macrophage lysosomes (37) as well as their derivation (38). Using
colloidal gold as a tracer, they could visualize the formation
of small pinocytic vesicles, their fusion into larger vacuoles,
and the delivery of colloid into lysosomes (38) (Fig. 5). Using
acid hydrolase cytochemistry at the electron microscope level,
they described a second input, dubbed "primary lysosomes"
from the Golgi apparatus (38).
By counting pinocytic vesicles under phase contrast, Zan
returned to his quantitative haunts. In a set of four papers
that would now qualify as "Brief Definitive Reports" he described the regulation of pinocytosis in mouse macrophages:
the need for energy metabolism and physiologic temperature
(39), the stimulatory role of anionic substances (40), and the
induction by nucleosides and nucleotides (41) and by anticellular globulins in calf serum (42). He repeatedly emphasized
the link between pinocytic activity and lysosome formation,
and later, the induction of lysosomal hydrolases by phagocytosis of digestible particles (59).
A series of films emerged from the Hirsch-Cohn Lab,
showing the formation and centripetal movement of pinocytic vesicles, and their interaction with phase-dense granules.
These films were somewhat less captivating than those that
Hirsch made earlier to show granule discharge during microbial phagocytosis. However, Cohn's films ofpinocytosis were
to prove more broadly relevant since they provide a lucid view
of the formation and fate of pinocytic vesicles, a widespread
cellular activity. The distinctive feature of macrophages was
not simply their pinocytic activity but the number of lysosomes and the large flow of contents from pinocytic vesicles
to lysosomes. Equally important, the cultured mouse peritoneal macrophage was now ready to be explored by many scientists in this and other laboratories.

Biochemical Features of Endocytosis
and Lysosomal Digestion
In 1966, Zan became a full professor and, together with
Hirsch, renamed their joint laboratory Cellular Physiology
and Immunology. The Rockefeller Institute for Medical Research had just become The Rockefeller University, and the
program for graduate study was underway.
Several students were to make substantial contributions in
the Hirsch-Cohn Lab. The first was Barbara Ehrenreich, who,
with Zan, did a remarkable group of experiments that out-
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lined the basic biochemical features of the pinocytic vesiclelysosome pathway.
Ehrenreich and Cohn fed radioiodinated human serum albumin (43) and tritiated hemoglobin (47) to mouse peritoneal macrophages so that intracellular digestion of soluble
proteins could be followed. They noted uptake into phase
dense granules by autoradiography. W h e n they chromatographed the labeled material that was released from the cell,
all of the label was associated with amino acids. Lysosomemediated digestion of internalized proteins was complete!
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Figure 5. The vacuolar system at the electron microscopelevel. This macrophage was cultivated in 50% serum for 42 h and exposed to 10 #g/ml
colloidal gold for 2 h before fixation. Particles of gold are present in all structures of pinocytic origin. On the upper left, a string of pinocytic vesicles
(Ves) contains gold, and one gold particle is present on the cell surface. Colloid is found in vacuoles scattered throughout the cytoplasm (l,fic). The
larger dense granules (Gr) are also labeled. In contrast, the Golgi saccules and associated vesicles (Go), as well as cisternae of the rough endoplasmic
reticulum, are free of gold. x 30,000 (38, Fig. 1).

The Mononuclear Phagocyte System

Figure 6. Permeabilitystudies of endocytic vacuoles. Following uptake by pinocytosis, the enzyme invertasedramatically shrinks vacuoles.
Phase-contrast micrographs. (Tbp)Immediatelyafter the addition of 500
/xg/ml of invertase. The cells had been cultivated for 24 h with 0.02 M
sucroseand contain numerous vacuolesthat havebeen swollenby uptake
of the impermeabledisaccharide sucrose. (Bottom) By 120 rain after invertase administration, all the large vacuoleshave disappearedleaving a residue of tiny dense granules, x2,500 (57, Fig. 7, a and d).

Ehrenreich and Cohn pursued the thoroughness of lysosomal digestion by administering peptides and oligosaccharides, including nonhydrolyzable D forms. They found that
the presence of undigested peptide or saccharide in the vacuolar
system exerted an osmotic pressure, and the vacuoles would
swell (57, 58). By monitoring vacuole swelling, Barbara and
Zan could determine if the peptide or saccharide were being
digested into permeable solutes, without the use of any radiolabels. They showed that most peptides and saccharides
had to be digested to their amino acid and monosaccharide
building blocks to avoid swelling of the vacuoles. Zan's favorite part of these experiments was the swelling induced
by sucrose. By feeding invertase to the macrophage, they initiated sucrose digestion and shrinkage of the swollen vacuolar
system (Fig. 6). These were some of the first experiments
on the permeability of intracellular organelles. As in the studies
8
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The origin of mononuclear phagocytes in situ became the
next focus. A starting point was the paper by William Bennett and Cohn showing that blood monocytes would develop
all of the now typical features of macrophages when placed
in culture (36). Similar events had been noted years before
at the Sir William Dunn School of Pathology in Oxford by
Robert Ebert and Howard Florey, who observed the development of extravasated monocytes in situ. In the 1960s at
the Dunn School, Alvin Volkman and James Gowans were
also providing direct evidence for the origin of tissue macrophages from blood monocytes. Zan was always fond of Oxford
University, especially the Dunn School and its monumental
contributions to antibiosis, experimental pathology, and cellmediated immunity. Zan was to spend a sabbatical there in
1988 as the Newton-Abraham Visiting Professor.
With Hirsch and Ralph van Furth, Zan carried out studies
that identified the blood monocyte as the precursor for tissue
macrophages, and the bone marrow as the source of monocytes, van Furth worked both in Leiden and during several
sabbatical visits at Rockefeller. Using [3H]thymidine labels
newly available from Eugene Cronkite at Brookhaven, van
Furth and Cohn subjected the pathway of bone marrow to
blood to tissues to quantitative and direct observation. They
found that monocytes were nonproliferating cells derived from
proliferating precursors in the marrow (53). van Furth and
Cohn monitored the movement of monocytes into the peritoneal cavity and elicited a recruitment of new macrophages
with various stimuli, one being the injection of calf serum.
Further studies in Leiden monitored the origin of Kupffer
cells, alveolar macrophages, and spleen macrophages. Later,
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with radiolabeled albumin and hemoglobin, Cohn and Ehrenreich surmised that the digestive capacities of living ceils had
to be extensive, since it was clear that actively pinocytic macrophages could be cultured for many days without any vacuolar
swelling.
Together with another graduate fellow, Zena Werb, Zan
studied cholesterol uptake metabolism and distribution in
mouse macrophages (69-71). They identified a cholesterol
esterase with an acidic pH optimum in macrophage lysosomes.
The enzyme was subsequently implicated by others in foam
cell development. The contributions of macrophages to atherosclerosis was an area that Zan very much wanted to pursue
further.
While lysosomes had been identified as biochemically distinct organeUes in the 1950s, Zan's experiments in the 1960s
put lysosomes into the dynamic context of intact cells. The
interplay with the plasma membrane via endocytic vesicles
was beautifully clear, and this pathway was capable of handling substrates to an extent limited primarily by an investigator's creativity. The completeness of digestion of most internalized substrates was established, and the input from the
Golgi apparatus a likelihood. The distinctive potential ofmacrophages was the extent of their scavenging and digestive
capacities, but the endocytic pathway was now opened for
further experimentation in all cells.

The Macrophage Plasma Membrane
and Membrane Recycling
The themes of endocytosis,lysosomes,and the mononuclear
phagocyte system that emerged in the 1960s are all too familiar now. Yet in 1970, the Hirsch-Cohn Lab served as a
rare focus for the cell biological study of host defense (82).
A group of students and postdoctoral investigators sought
to work with Zan and Jim, and a flurry of new activities

Table 1. Leiden Conferences on Mononuclear Phagocytes
Mononuclear Phagocytes
Blackwell ScientificPublicationsLtd., Oxford, 1970
Conference:September2-5, 1969
Mononuclear Phagocytes in Immunity, Infection, and Pathology
BlackwellScientificPublicationsLtd., Oxford, 1975
Conference:September2-7, 1973
Mononuclear Phagocytes: Functional Aspects
Martinus NijhoffPublishers, The Hague, 1980
Conference:September17-24, 1978
Mononuclear Phagocytes: Characteristics, Physiology and Function
Martinus NijhoffPublishers, Dordrecht, 1985
Conference:May 9-16, 1984
Mononuclear Phagocytes: Biology of Monocytes and Macrophages
Kluwer AcademicPublishers,Dordrecht, 1992
Conference: May 13-16, 1991
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emerged. The mouse peritoneal macrophage was readily accessible, and experiments became far less burdensome when
tissue culture plastic replaced glassware, and CO2 incubators
replaced various gassed containers. While not evident from
Zan's bibliography, a critical individual in the 1970s was Samuel
Silverstein, who provided much expertise in cell biology and
led most of the work on phagocytosis and viruses. Many individuals enjoyed both Sam and Zan as mentors, even though
the two had few joint publications (83, 125, 144, 145).
By 1970, Zan's interests in the vacuolar system shifted substantially, from contents (acid hydrolases plus substrates captured by endocytosis) to containers (the plasma membrane
and membranes of the endocytic apparatus). This was the
time when the first plasma membrane protein, red cell glycophorin, was being characterized by Vincent Marchesi. Two
peroxidase enzymes proved fruitful early on. The first, lactoperoxidase (LPO) entered the lab because of Zan's friendship with Seymour Klebanoff. Klebanoff studied thyroid metabolism at Rockefeller years earlier, and afterward found that
neutrophil peroxidase, together with hydrogen peroxide, had
microbicidal and halogenating activities. Zan always seemed
intrigued by the fact that hydrogen peroxide, a time-honored
antiseptic, is a substance used by phagocytes to kill microbes
and other cells (see below).
Challenged to develop better methods for analyzing the
plasma membrane biochemically and functionally (114), Zan
used LPO to attach radioiodine covalently to membrane proteins in living cells. Ann Hubbard, in graduate studies with
Z,an, devised the relatively gentle system whereby glucose oxidase and glucose were used as a source of H202. She then
added LPO in the cold and was able to selectively iodinate
externally disposed polypeptides of the plasma membrane.
Red cells were iodinated first (75) and then L cell fibroblasts
(102). In the latter, it became possible to document the relatively slow turnover of most plasma membrane proteins in
cultured cells. When Hubbard and Cohn coaxed L cells to
phagocytose latex particles, they found that the phagocytic
vacuole membrane contained a representative sample of plasma
membrane polypeptides, and that phagocytosis was associated
with a much more rapid turnover of these polypeptides (103).
Werb made similar findings on the effect of phagocytosis on
the turnover of the plasma membrane enzyme, 5'-nucleotidase (79).
The other peroxidase, horseradish peroxidase (HRP), was
chosen by Ralph Steinman and Cohn because of the relative
ease of quantitation (with the same enzymatic assay being
used by Hubbard to standardize her LPO) and visualization
(with the new electron microscopic diaminobenzidine method
that had been introduced by Richard Graham and Morris
Karnovsky). Steinman and Cohn used HRP to quantitate
solute uptake into cultured macrophages (76) and fibroblasts
(93). The method did not require radiolabels and totally
replaced the counting of pinocytic vesicles that had been used
in so much of the earlier work. In spite of the vigorous pinocytic activity of macrophages, Steinman and Cohn found the
amounts of solute that were internalized in the fluid phase
to be extremely small relative to the applied load. However,
they described a dramatic enhancement of uptake when
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van Furth, Fedorko, and Hirsch did dectron microscope studies
on bone marrow colonies containing precursor monoblasts
and promonocytes, and they described production capacities
and kinetics.
These experiments led to a redefinition of the reticuloendothelial system (RES) (78). The well-known capacity of the
RES to clear colloids, organisms, and antigens could now
be attributed to the endocytic pathway of the mononuclear
phagocyte system. This work went beyond a new nomenclature to a redefinition based on developmental origins and cell
biological features. Mononuclear phagocytes in other microenvironments were denoted and would attract Zan's attention
later, for example, macrophages in the lung (202, 211, 277,
302), liver (256, 257), and spleen (328). Once cell biological
criteria had been brought to the identification of mononuclear
phagocytes, the foundation was in place for the laboratory
to pursue other distinct cell systems, especially endothelial
cells and dendritic cells.
The vital interaction with van Furth also produced five
conferences on mononuclear phagocytes, held in Leiden, that
brought together many investigators in the expanding macrophage universe. The volumes describing the deliberations
of these meetings, all edited by van Furth (Table 1), provide
a detailed survey into the Zan Cohn era of macrophage biology. Zan's honorary degree from Rikjsuniversiteit in Leiden
in 1990 was very special to him.

10

Aley also applied the methods that were being used to study
the macrophage cell surface to several microbes that were of
great interest to the lab (below): Trypanosomacruzi (190, 205),
Leishmania donovani (224), and Entamoeba histolytica (151,
152, 239).
With graduate fellow Margaret Kielian, Zan monitored
phagosome-lysosome fusion in macrophages (154, 184, 185).
Perhaps of greatest interest were the anionic compounds that
blocked fusion (203, 204). At the same time Hirsch, Silverstein, and Marcus Horwitz were engaged in studies where
intracellular microorganisms interfered with normal fusion
events. At the time of his death, Zan was poised to identify
compounds used by pathogenic microorganisms to establish
their unique intravacuolar environments, particularly virulent Mycobacterium tuberculosis.
The Macrophage as a Secretory Cell

Z.an, together with a former graduate fellow, Siamon
Gordon, uncovered the profound secretory function of macrophages. The array of secretory products were to prove extraordinarily diverse. Macrophages not only used the traditional pathway of protein secretion via the rough endoplasmic
reticulum but also released other products via enzymes of
respiration and arachidonic acid metabolism that were associated with the plasma membrane.
The first evidence involved lysozyme (89). Prior work had
shown that lysozyme, a granule-associated muramidase in neutrophils, could be regurgitated acutely during phagocytosis.
Elliot Osserman had found a huge output of lysozyme in
the urine of patients with monocytic leukemia. Gordon and
Cohn, searching for differentiation markers for macrophages
to be used in their somatic cell genetic studies (63-66), noted
that many different populations of macrophages released lysozyme continously for days and without a phagocytic challenge. The secretion rate amounted to 2.5% of total cell protein per day. Then, plasminogen activator (fibrinolytic activity
in the presence of plasmin) was studied and found to be secreted
copiously by thioglycollate-elicited, but not resident, macrophages. Gordon and colleagues found that, unlike the situation with lysozyme, plasminogen activator release was inducible and proceeded in a two-step fashion that was to become
standard for many subsequent macrophage activities. The cells
first were primed with LPS and then provokedwith a phagocytic meal (90). Another important subsequent finding was
that the fibrinolytic pathway could be primed during T cellmediated immunity in situ (129).
Zan and colleagues, especially Carl Nathan, then turned
to metabolites of oxygen, another class of products that macrophages can release (130, 142, 144-146, 160, 183). They noted
differences in superoxide and hydrogen peroxide output from
macrophages elicited by distinct inflammatory and immune
stimuli. They associated these differences with changes in
macrophage-mediated microbial and tumor killing (seebelow).
William Scott and Cohn uncovered and pursued a third
class ofmacrophage secretions, arachidonic acid metabolites.
Again, a major contribution was made by a graduate fellow,
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HRP-anti-HRP immune complexes were administered and
internalized via the Fc receptor (77).
Because internalized HRP could be visualized at the electron microscope (EM) level, Steinman and Cohn could take
stereologic approaches to measure the size of the intracellular compartments that were labeled by HRP, as well as the
kinetics with which these compartments filled. The phenomenon of extensive membrane recycling during pinocytosis
became apparent (117). They estimated that the area of membrane surrounding newly formed pinocytic vesicleswas equivalent to an influx of half the macrophage surface area every
33 minutes. Yet they found that the volume and area of the
compartments in which HRP solute accumulated was considerably less than the volume and area of internalized vesicles.
They made qualitatively similar findings in L cell fibroblasts,
the cells in which Hubbard documented a relatively slow turnover of membrane proteins. They concluded that, during the
uptake and delivery of HRP to digestive lysosomes, there
likely was an enormous flow and recycling of vesicle membrane into and back out of cells (117, 231).
Graduate fellow William Muller amalgamated the LPO
and HtLP findings to approach the recycling of membrane
proteins directly. This time Muller covalently linked LPO
to latex beads, fed the beads to macrophages, added glucose-glucose oxidase to generate hydrogen peroxide, and
thereby covalently linked 125I to the disposed polypeptides
of intravacuolar membranes (157). Muller could then observe
that membrane polypeptides that had been iodinated from
within the cell would rapidly return to the cell surface and
then back into the cell (158, 231). Ira Mellman used internalized soluble LPO to iodinate pinocytic vesicle membranes.
He found that the labeled, internal polypeptides resembled
those on the plasma membrane (156). With the advent of
monoclonal antibodies, specific membrane components could
be identified on cell surface, phagosome, and pinocytic vesicle
membranes (158, 227). Mellman documented a selective increase in the turnover of a plasma membrane receptor during
Fc receptor-mediated phagocytosis (225).
In the 1970s, Zan's emphasis on the plasma and vacuolar
membranes of macrophages was far from limited to these peroxidase studies. The array of approaches and topics that anteceded the peroxidase work, or were studied simultaneously,
included the behavior of macrophage membrane markers
following the formation of macrophage-melanocyte heterokaryons (63-66), a study that provided lovely examples of
the fluid-mosaic model of membrane structure that was being
developed at that time by Jonathan Singer; the uptake and
turnover of the plasma membrane enzyme 5'-nucleotidase (79,
112, 113); cell surface sites accessible to lectins (87, 88), to
antimacrophage antibodies (74), and to modification with
trinitrophenyl groups (140); the isolation of Fc receptor-negative variants (150); uptake of cholesterol into macrophages
(69-71); and the modification of fatty acids in macrophage
phospholipids (121, 155). Characteristically, Zan and colleagues
carried out all of these perturbations in living ceils and with
microscopic monitoring.
Graduate fellows Nadia Nogueira, David Lepay, and Stephen

Discovery of Dendritic Cells
In 1966 the first success at inducing primary antibody responses was reported by Robert Mishell and Richard Dutton
in mouse spleen cell suspensions. Donald Rowley and Donald
Mosier found that plastic adherent cells, presumably macrophages (there were few other alternatives at the time), were
11
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required as accessories by the immunologically competent lymphocytes. Early on, the function of the macrophage was perplexing. Zan's experiments on the distribution and fate of
protein antigens in peritoneal macrophages showed that these
were thoroughly degraded (43, 47, 57, 58) but failed to identify
a postulated reservoir of intact protein on the macrophage
cell surface (76, 77). Patrick Chen and Hirsch found that enriched populations of peritoneal macrophages could exert two
effects on the antibody response. One was an enhancing effect
at low doses of macrophages, but this was primarily at the
level of lymphocyte viability and could be bypassed by adding
2-mercaptoethanol. A second was a strongly inhibitory function that was evident at doses corresponding to just 2-3%
of the cultured cells. At the time, some papers concluded
that the function of macrophages was MHC restricted, while
others concluded otherwise.
Steinman and Cohn switched from peritoneal cells to spleen
cells to understand the induction of immune responses in a
major lymphoid organ of the mouse. They encountered an
irregularly shaped population of cells, named "dendritic cells"
(84). In spite of years of experience with macrophages from
many tissues and species, neither Cohn nor Hirsch had ever
seen a phagocyte that resembled these dendritic cells in terms
of organelles (Fig. 7) and motility. At that time, there was
extensive experience in the lab with the differentiated features of phagocytes. Michel Rabinovitch had pursued in some
detail the.abundance and phagocytic role of Fc receptors in
macrophages. Hirsch and graduate fellow Sally Zigmond were

Figure 7. Distinguishingmacrophagesand dendriticcellsby differences
in lysosomalcontent. Phase-contrast(top) and bright-fieldmicrographs
(bottom) after staining for lysosomalacid phosphatase. The macrophage
(noteruffles,vesicles,refractileinclusions)exhibitsconsiderableacidphosphatase in a perinuclearposition. The dendriticcell has a few smallreactive granulescloseto the nucleus(arrows). x2,700 (84, Fig. 4, a and b).
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Carol Rouzer. They showed that the 20-carbon polyunsaturated arachidonic acid (20:4) constituted a major fraction (25%)
of the fatty acids of macrophage phospholipids. The latter
could be substituted close to equilibrium by an overnight culture in [3H]arachidonic acid, thereby allowing the group to
quantitate subsequent metabolism by the cyclooxygenase and
lipooxygenase pathways. By high performance liquid chromatography (HPLC), they were able to identify many of the
20:4 products released from macrophages.
Scott, Cohn, and colleagues showed that the macrophage
was in fact a major cellular source of several arachidonic acid
metabolites, many of which were known to have major effects
in inflammation and on smooth muscle and vascular tone.
They found that in resident macrophages, particle uptake triggered the secretion of large amounts of prostaglandins, both
PGE and PGFlol (170). Strikingly, they also proved that macrophages were an active source of the elusive leukotriene C
(LTC) (169, 170). This glutathione-lipid adduct was otherwise known as one of the trace "slow reacting substances"
that cause spasms of airway smooth muscle. They noted that
mouse pulmonary macrophages synthesized leukotrienes C,
D, and E (211), while human alveolar macrophages made substantial amounts of the chemotactic agent leukotriene B4
(202). Rouzer, Scott, and Cohn discovered that the release
of LTC from macrophages could be triggered by IgE-antiIgE complexes (210, 212), a remarkable finding considering
the prior emphasis that IgE immune complexes worked primarily on mast cells. Rouzer could block LTC metabolism
selectively by applying buthionine sulfoximine, an inhibitor
of glutathione synthesis (193, 209). Finally the group described
that macrophages could utilize exogenous 20:4 and other
precursors to rapidly synthesize prostacyclin and hydroxyeicosatetraenoic acids (214). Interestingly, arachidonic acid metabolism was one of the few macrophage activities to be downregulated in otherwise "activated" cells (215). This could occur
locally within restricted tissue environments (277).
Within a period of 15 years, Zan had created a vigorous
environment that was attractive to graduate students, postdoctoral fellows, junior faculty, and sabbatical visitors. This
in turn led to the development of three major avenues of macrophage biology, each with substantial impact on the broader
areas of cell and immunobiology: the pinocytic-lysosome
pathway, the mononuclear phagocyte in vivo, and several secretory roles. The function of the macrophage had changed from
a "big eater" to the "versatile element of inflammation" (221).
These avenues of macrophage function provided the underpinnings for several new areas (see below) that would emerge
and that directly pertained to Zan's interests in host defense
mechanisms.

Macrophage Activation: Antimicrobial
and Antitumor Activities
Zan's early work focused on the "constitutive" microbicidal activities of phagocytes, but he often wrote in reviews
about their "acquired" kiUing capacities. The concept of qualitative changes in macrophage antimicrobial function was pioneered by scientists at the Trudeau Institute, where Zan was
a longtime advisor and trustee. George Mackaness, who had
been a member of the Dubos-Hirsch Lab in the late 1950s,
found that the microbicidal activity of macrophages increased
during murine listeriosis and tuberculosis. Robert North
provided evidence that both thymus-dependent lymphocytes
and newly recruited macrophages were critical for resistance
in vivo.
In the mid 1970s, the activation of peritoneal macrophage
function took center stage, if such a thing were possible in
Zan's lab! Zan emphasized that "activation" was a qualitative
or quantitative increase in discrete, measurable functions relative to the baseline in resident peritoneal macrophages (126).
Zan and colleagues studied many properties, and typically
12

in a number of populations elicited by different stimuli. Some
changes included an increase in pinocytic activity (100) and
turnover of the ectoenzyme 5'-nucleotidase (112) with Paul
Edelson; enhanced production of plasminogen activator with
Gordon (129), Jay Unkeless, and Edward Reich; enhanced
release of superoxide anion (130, 183) with Richard Johnston; increased spreading (110, 138, 139) with Celso Bianco
and Otto G6tze; and altered plasma membrane composition
and turnover (173) with Helen Yin.
However, most investigators in the field considered the pinnacle of activation to be enhanced antimicrobial and antitumor
activity. Zan and colleagues encountered such capacities in
macrophages taken from mice infected with viable BCG and
T. cruzi. Zan considered the studies on T. cruzi, initiated with
graduate fellow Nadia Nogueira, to be a high point. This
obligate intracellular protozoan parasite causes Chagas' disease in humans. First they attended to the organism itself
and learned to isolate the pathogenic trypomastigote form
(104). Remarkably, when they followed the uptake and intracellular fate of cultured trypomastigotes, they observed that
parasites escaped from the uptake vacuole and grew in the
cytoplasm (115). However, in macrophages that were taken
from mice that had been infected with either T. cruzi or BCG,
and then challenged with the corresponding specific antigen
(so-called "immune-boosted" macrophages), Nogueira and
Cohn noted killing in 75% of the internalized parasites (123).
When a lymphokine-rich conditioned medium was produced
by spleen cells from infected mice and applied to otherwise
nonresistant phagocytes in vitro, the group induced sterilizing
resistance and other parameters of macrophage activation (Fig.
8) (124, 131). They made similar findings with human monocytes (207). Whereas prior studies with other organisms had
produced bacteriostasis and/or short-lived cidal effects, Zan's
T. cruzi work provided the precedent that products of immunologically active spleen or blood cells could change the
macrophage from a susceptible to a sterilizing cell.
Henry Murray proceeded to analyze another obligate intracellular protozoan that was readily visualized, Toxoplasma
gondii. This was familiar territory because of earlier studies
by Thomas Jones and Hirsch in the lab. This class of organisms
again allowed one to monitor microbial fate directly by microscopy and to ensure that microbicidal effects were occurring within the cell and not extraceUularly. Murray and Cohn
proceeded to outline the sensitivity of T. gondii to hydrogen
peroxide (141), the capacity of scavengers of oxygen metabolites to block killing by immune-boosted macrophages (142,
161) (Fig. 9), and the tight correlation between enhanced oxidative metabolism and killing (160).
The work was then taken into the realm of tumor resistance by Carl Nathan, who had previously discovered with
Richard Root that appropriately activated macrophages could
produce as much hydrogen peroxide as polys. Along with
Silverstein, the group now demonstrated extracellular, hydrogen peroxide-dependent killing following the triggering with
pharmacologic agents (144, 145) and antibody-coated tumor
cells (162, 163). Tumor cell killing was manifest only in appropriately activated macrophages, especially those obtained
from BCG- and C. parvum-primed mice. Tumor cell antiox-
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directly observing phagocyte chemotaxis and motility. Gordon
and Cohn were utilizing several phagocyte differentiation
markers in their macrophage-melanocyte fusion studies
(63-66). When Steinman and Cohn evaluated this repertoire
of known macrophage traits in dendritic cells, not a single
resemblance to macrophages was apparent (91, 92). Dendritic
cells lacked the abundant membrane ATPase and acid phosphatase that were typical of macrophages; the cells had little
phagocytic activity in culture and in vivo; the dendritic cells
detached from culture surfaces and had poor viability; their
turnover in spleen was rapid; and in situ, dendritic cells were
primarily localized to the white pulp instead of the red pulp
(105). Soon the group noted the juxtaposition of dendritic
cells with developing antibody-forming cells (106), but the
turning point was a method to prepare enriched populations
of dendritic cells and macrophages, both trace populations
in mouse spleen suspensions (148). To do so, Steinman took
advantage of the fact that dendritic cells lacked Fc receptors.
Cohn, Steinman, and graduate fellow Michel Nussenzweig
then documented dramatic differences between the two cell
types in MHC class II expression (148), surface markers (192),
and T cell stimulatory function (166). The findings in mouse
spleen were evident in other tissues and species, including
human blood, as studied by graduate fellow Wesley Van
Voorhis (232). Dendritic cells therefore represented a new
leukocyte distinct in morphology, phenotype, and function
from phagocytes and lymphocytes. Mechanisms underlying
the induction of primary immune responses by dendritic cells
in vitro and in vivo were now accessible.
Zan played another role in uncovering the dendritic cell
system, one typical of other research areas in the lab. Frequently invited to organize meetings on mononuclear phagocytes, Zan helped organize a symposium in Japan in 1980.
Meetings engender new collaborations, in this case a longstanding effort with Kayo Inaba in Kyoto, which was to prove
essential to the characterization of dendritic cells.

Figure 8. Phase-contrastmicrographs of proteosepeptone-inducedmacrophages 72 h afterinfectionwith T. cruzi. (Top) Cellscultivatedin medium
alone for the whole time. Manyof the macrophagesare parasitized(arrow).
(Bottom) Cellscultivatedin mediumcontaining25% of BCG-inducedspleen
cell factor. The burden of protozoa has been reduced by the lymphokine
treatment, x600 (131, Fig. 4).
idant defenses could be compromised in vitro and in vivo
(164, 188, 199, 220, 252), and this led to enhanced killing.
In other interesting experiments, the group induced killing
of targets, by applying peroxidase and a halide to cells (81),
and sensitized organisms with peroxidase to small amounts
of H202 (206). Therefore, Zan and a talented group of clinicaUy trained individuals helped expand the long-standing topic
of macrophage activation during T cell-mediated immunity
to several important targets and to concrete ideas on mechanism.

Cytotoxicity Mediated by Pore-forming Proteins
Studies on the biochemical basis for cell-mediated cytotoxicity were extended to other systems with John Ding-E
Young, first a graduate fellow and then faculty member. Young
13
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and Cohn emphasized killing by cytolytic lymphocytes, both
T and NK cells. The paradigm proved to be different from
the macrophage. They showed that, instead of oxygen metabolites, killer cells released a pore-forming protein by granulemediated exocytosis. Young isolated from killer cell granules
this "perforin" (260, 285, 291), as well as two serine esterases
(294). Young characterized the lesions that were created by
perforin deposition in targets as large ion-carrying pores and
visualized the pores by electron microscopy (292). He found
these functional properties of perforin to be similar to the
terminal complex of the complement cascade, to which perforin was found to have other homologies (296, 298). Young
and colleagues found that the release of perforin could be
induced by ionophores (299). They further identified a calcium and perforin-independent killing pathway (316) and pursued other cytolytic factors and cell types such as eosinophils
(289), mast cells (312), and the agent of amoebic dysentery,
Entamoeba histolytica (219, 262).

Macrophage Signaling via a Major Substrate
of Protein Kinase C (PKC)
The lab directed its early efforts in the signaling arena to
the prototypic Fc3, receptor, which is pivotal in triggering
macrophage phagocytic and secretory functions. Mellman and
Unkeless had purified the receptor some years earlier. Young
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Figure 9. Phasecontrast micrographsof macrophages24 h afterinfection with T. gondii. (Top) Inhibition of toxoplasmareplication by normal
macrophages cultivated 18 h before infection in heart infusion broth (8
mg/ml) and 5% toxoplasmalymphokine. Only a few organisms are seen
(arrows). (Bottom) Samemacrophagesafter exposureto exogenouscatalase
(2 mg/ml) showinggrowth of toxoplasma(arrows). x 1,200 (160, Fig. 8).

Endothelial Transmigration or Monocyte
Diapedesis
Zan always emphasized in reviews the need to understand
the recruitment of monocytes from the blood stream, a
phenomenon that underlies so many contexts, including
delayed-type hypersensitivity (DTH), granuloma formation
in chronic infectious diseases, and perhaps atherosclerosis. Eva
Cramer, Nicholas Pawlowski, and Scott were the first to approach endothelial cells in the lab. They found that the macrophage product leukotriene C could stimulate prostacyclin
synthesis by endothelial cells (222) as well as the transendothelial migration of neutrophils (242). Patricia Detmers,
Marco Baggiolini, and Zan showed that interleukin-8 (IL-8)
could activate the integrins of neutrophils and enhance the
binding of polys to endothelial cells (349, 354). Zan and colleagues then identified an experimental model in which human
blood monocytes selectivelybound and transmigrated through
the junctional complexes of human endothelium (259,329).
The exploration of the molecular basis for monocyte transmigration became feasible when Muller rejoined the lab to
set up a vascular biology unit. He rendered the tissue culture
model appropriate for quantitative studies and also developed
a monoclonal antibody to an antigen that was abundant in
endothelial junctions (344). Later identified as platelet/
endothelial cell adhesion molecule 1 (PECAM-1), this proved
14

to be the first molecular species that both localizes to endothelial junctions and is required for monocyte diapedesis.

Manipulating Cell-mediated Immunity with
Lymphokines in Human Infectious Disease
Early in the 1980s, Zan was at last ready to study macrophage function directly in the setting of human infectious
disease. With Gilla Kaplan, he initiated a program to study
leprosy and established collaborations in Colombia, Brazil,
India, Nepal, Ethiopia, and the Philippines. Suitcases packed
with supplies for experiments became part of the lab environment.
Cohn and Kaplan chose leprosy for many reasons. Clinically, it remains a major scourge. Experimentally, much of
the critical pathology is accessible in the skin. Biologically,
the mechanisms underlying the spectrum from lepromatous
to tuberculoid poles of the disease were pertinent to the lab's
interests. Lepromatous leprosy was in essence an antigenspecific immunodeficiency expressed in the form of a microbially permissive macrophage, while tuberculoid disease and
some reactional states were manifestations of heightened T
cell immunity. So the time had come. Zan always looked forward to bringing his experiments into the realm of human
disease, and he understood the reciprocal but too often forgotten principle that the study of disease stimulates new insights.
The immunologic changes in leprosy previously had been
analyzed at the level of blood cells. Zan and colleagues focused on the skin lesions. Graduate fellow Van Voorhis noted
that the tymphocytes in skin infiltrates were not a representative sample of those in blood. CD4 § T cells predominated
at the tuberculoid pole, while a scant CD8 + infiltrate characterized the lepromatous pole (218). A demanding series of
electron micrographs outlined the intravacuolar location of
Mycobacterium leprae in macrophages in lepromatous disease,
and the presence of what appeared to be activated lymphocytes at the tuberculoid pole (223). The group made comparable findings in examining leishmaniasis, especially in the
mouse model. They noted that the makeup of infectious loci
in cutaneous and visceral infections reflected the efficacy of
the local immune response rather than a general sample of
blood cells (307, 327).
In studies of blood cells from lepromatous leprosy patients,
Zan and colleagues outlined a deficiency in the production
of IFN-3~ and macrophage-activatingcytokines following challenge with M. teprae antigens (228, 243). When they found
that low levels of responsiveness in T cells from some patients could be boosted by interleukin 2 (IL-2) (254), they
turned to reversing the deficit in situ. Two approaches were
taken and both proved fruitful. One was to inject purified
protein derivative (PPD), i.e., antigens from M. tuberculosis.
Although lepromatous patients are unresponsive to the
lepromin antigen from M. leprae, the patients can exhibit a
typical DTH response to the tuberculin skin test antigens
from M. tuberculosis (325). Kaplan, Cohn, and colleaguesnoted
a substantial decreasein acid fast bacilli at the DTH site (326).
So the chronically parasitized disease site did not behave as
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found that FcR triggering could depolarize macrophages (235)
and induce ion fluxes (264), including an increase in intracellular calcium (250). Scott and colleagues showed that the secretion of arachidonic acid metabolites only required attachment
of an antibody-coated particle to surface Fc receptors (168).
With the arrival of Alan Aderem, the study of signal transduction for enhanced arachidonic acid, or 20:4, metabolism
continued (238, 251), but an important change was to emphasize one of Zan's favorite stimuli for enhanced macrophage
function (10, 17), namely the lipopolysaccharide (LPS) from
the cell walls of Gram-negative organisms.
Aderem defined sequential signals for the induction of 20:4
metabolism by LPS. LPS would first prime the macrophages,
and then the cells could be provoked with such triggers as
PMA, latex particles, or calcium ionophore (271, 273, 319).
Aderem decided to pursue the mechanism of LPS function
at the level of protein myristoylation and noted specific LPSprimed species (272). He proved that a species that migrated
with an apparent molecular mass of 68 kilodaltons (kD) was
a major substrate of PKC (318) and was later termed myristoylated alanine-richC-ldnase substrate (MARCKS). LPS-induced
myristoylation targeted MAR.CKS to membranes, permitting access to PKC. Aderem soon defined the capacity of
MARCKS to interact with actin. The group described how
interferon 3, (IFN-"r'), the prototype activator of macrophage
function, induced the myristoylation of a distinct 48-kD macrophage protein (320). Although the link to 20:4 metabolism remained unspecified, Zan was at last seeing connections
being unravelled between LPS and IFN-3', the macrophage
surface, and the cytoskeleton.

Figure 10. T cellaccumulationduringthe responseto intradermalIL-2.
Histologic(hematoxylinand eosin)(a) and immunohistologicstainingof
sections with mAbs that recognizeall T cells (CD5) (Leu-1)(b and c).
Biopsies were taken 96 h after I1.-2injections (2 x 10 #g). At this early
time, the majorityo f t cells are of the CD4 + subset, xl00 (a); xS0 (b);
and x 200 (c) (338, Fig. 3).
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markedly (see below). So again, local M. leprae were not associated with nonspecific suppression of the many cellular
responses to IL-2 or to PPD (337). In human cutaneous leishmaniasis, IL-2 injections also brought about a local decrease
in parasite numbers (347).
Kaplan and colleagues then found that chronic, local injections of IL-2 had systemic effects as well. There were decreased bacillary numbers in slit smear preparations from the
ear (357), and increased killer cells (336, 355) and responses
to proliferative stimuli (348) in blood.
These experiments with relatively low doses of intracutaneous IL-2 were seminal in three respects. First, the observed responses to IL-2 provided a mechanism whereby a
local response by antigen-specific T cells in DTH marshals
the characteristic histologic response. Second, the response
to IL-2 and to PPD unveiled changes in the keratinocytes that
immediately caught the attention of Kaplan and Cohn (284).
There was a marked and rapid keratinocyte hyperplasia, as
well as an increase in expression of two molecules, MHC
class II and a cytokine termed "y interferon-induced protein
(3~-IP-10) that had been discovered by graduate fellow Andrew Luster, Unkeless, and Jeffrey Ravetch. When the effects
of cytokines on keratinocyte growth were studied in vitro,
GM-CSF but not IL-2 was noted to be stimulatory (324).
So IL-2 injections in situ seemed to be enhancing local release
of IFN-T and GM-CSF. Kaplan and Cohn therefore tested
GM-CSF directly and uncovered striking increases in dendritic cell numbers and in the rate of wound healing (364).
Third, the systemic enhancing effects of ILo2 suggested that
chronic low-dose intracutaneous IL-2 might be used therapeutically in T cell deficiency states, much like chronic intracutaneous insulin is used in diabetics, Zan argued. These
sets of findings that emerged by direct observation of the
IL-2 injection site in leprosy are noteworthy when compared
with the toxicity and limited efficacy in other studies with
high dose, intravenous IL-2.
As the leprosy work progressed in the 1980s, Zan and colleagues naturally transferred attention to two major diseases
in which the causative agent exhibits a tropism for macrophages, AIDS (322) and tuberculosis (368). Several clinically
trained individuals joined the lab to study white cell function in HIV-1- infected patients. They documented the proliferative potential of CD4 + T cells (340) and the HIV-1 burden
in monocytes (358). Patient studies also were begun to evaluate
the effects of intracutaneous IL-2. While II,-2 had proven
ineffective in prior work, the use of high doses and the intravenous route could have been compromising. The first studies
with Juliana McElrath and Hedy Teppler encouraged Zan.
They found that the immunocompromised, HIV-l-infected
individual could mobilize a typical cell-mediated reaction to
IL-2 in the skin (350) and would show systemic effects such
as a boost in IL-2-responsive killer cells (369, 370). A program to enhance the immune system of immunocompromised
individuals was therefore underway.
More recently, a program in tuberculosis began under the
direction of Kaplan. In one set of experiments, Anthony
Molloy, the last graduate fellow to work with Zan, carefully
monitored the features of human monocytes that were sup-
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if it were nonspecifically suppressed, a theme proposed in the
literature as a result of tissue culture studies. Instead, the disease site had the potential to respond, and relatively rapidly.
The second approach was classically simple and was initiated by Cohn, Nogueira, and Nathan. Why not inject the
T cell products, which lepromatous patients could not make
in response to M. leprae antigens, directly into the skin and
observe the consequences? These products had just become
available as a result of recombinant DNA technology. IFN-3/
was tested first (287) and found to replay certain features of
DTH. Multiple injections of IFN-3, led to more pronounced
clearance of acid-fast bacilli (304, 339).
IL-2 was tested next. Kaplan and Cohn found that remarkably, this lymphokine marshaled all the cellular changes that
typified standard, antigen-elicited, DTH reactions, only faster
(338). Monocytes and T cells selectively emigrated into the
injection site, which became classically raised and indurated
within a day (Fig. 10). Parasitized macrophages became difficult
to identify by electron microscopy, dendritic cells accumulated intradermally, and the overlying epidermis changed

porting the growth of BCG mycobacteria. Another set of
experiments was based on an outgrowth of the leprosy work,
the observation that thalidomide could decrease the production of TNF in patients with erythema nodosum leprosum
and in stimulated cultures of human monocytes (361). At
his death, Zan was organizing an expanded and multifaceted
program in tuberculosis research and was pursuing the promising initial studies in wound healing and HIV-1 infection
(above). For each of these efforts, The Rockefeller University Hospital was as critical a part of the Laboratory as when
Zan arrived to work with Dubos and Hirsch 35 years earlier.

Ralph M. Steinman and Carol L. Moberg
For the Editors

Several individuals helped with this tribute: Maclyn McCarty, Ralph van Furth, Samuel Silverstein, Siamon Gordon, Carl Nathan, Gilla Kaplan, Ira Mellman, William Muller, Nina Bhardwaj,
Joan Muller, Judy Adams, and William Swiggard.
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The Esprit of a Physician-Scientlst
Zan's professional activities extended to many other spheres
of academic medicine. He played significant editorial roles
for many journals, not just this one. He was an advisor to
several institutions: Bates College, where he received a B.A.
in 1948; Harvard Medical School and the Massachusetts
General Hospital, where he received his medical education
from 1949 to 1955; the Trudeau Institute; Roswell Park Cancer
Institute; the New York Blood Center; and the National Institutes of Health. Together with Jim Hirsch and Alexander
Beam, Zan organized, with Cornell University Medical College, one of the first medical scientist training programs for
the combined M.D.-Ph.D. degree. Also, Zan vigorously supported The Rockefeller University Graduate Program from
its inception, contributing to the professional development
of numerous graduates. Ph.D. students are coauthors of 80
of his 370 publications, and their postdoctoral work is featured in dozens more. Zan's leadership of the laboratory was
strengthened by his gifted assistant, Mrs. Grace Silvestri.
Two professional concerns were foremost for Zan. One was
The Rockefeller University Hospital. Zan regarded himself
as a "physician-scientist" who was most challenged by the
biological venue of human disease. In his last 10 years, Zan
was fully occupied by leprosy, AIDS, and tuberculosis, and
the Hospital's in- and out-patient facilities were vital to his
bench observations. Zan stressed that the Hospital served as
the focal point for many of the finest accomplishments by
Rockefeller investigators, whether their training was Ph.D.,
M.D., or both. This was more than happenstance. Problems
of human disease remain intrinsically of great interest and
challenging complexity, and appropriate animal models are
often not available for many major illnesses. Zan therefore
enthusiastically assumed the position of Vice President for

Medical Affairs in early 1992. Together with Physician-inChiefJules Hirsch, he was energizing a successfulnew Clinical
Scholar Program for research in human disease, particularly
the eight major conditions that currently are the Hospital's
core.
The other focus for Zan was his editorial responsibility
toward this Journal. The board meets weekly to discuss the
submitted articles and the referees' reports. The editors of
any journal face demanding responsibilities, but the weekly
Journal meeting in a special way distributes the demands, provides a time to learn and to be with colleagues, and improves
on fairness and consistency. Zan insisted that these pages be
the place to describe the newest developments, and that there
be sufficient space to document conclusions adequately and
to pursue mechanisms in detail. Over the years it has become
more difficult to publish the extensive work-ups that exemplified Zan's early papers. Yet the Journal still looks for
the qualities that made Zaffs work so substantial and enduring:
novelty, clarity, and a mechanistic analysis that is quantitative, direct, and multifaceted.
Zan's personal qualities, of which the editors were so fond,
were familiar to many. A quiet gentleman, he was known
for his brevity, wit, modesty, and fairness. He was quick to
share his broad experience and insight. Professionally, his
greatest pleasures were the exploits of young people, and his
greatest concerns were for the integrity and support of university life. He loved the sea and its wildlife, and he shared many
personal interests with his wife Fern, his son David, his
daughter Ellen, and numerous friends.
Zanvil Cohn was recognized in Leiden as "the founder of
modern research on macrophages" His alma mater, Bates College, honored him for "his intellectual courage to explore
the worlds of living cells, and for his quiet contributions of
knowledge which may heal the sick" His scientific legacy
extends deeply into cell biology, immunology, and infectious
disease. To The Rockefeller University and the Laboratory
of Cellular Physiology and Immunology, he was a warm,
sensitive colleague who nurtured an array of scientificfindings
and who mentored the careers of dozens of individuals. To
the editors of TheJournal of Experimental Medicine, he upheld
and fostered a tradition of innovation and depth, helping to
guide the growth and international excellence that embrace
our profession. We all miss this prince of a man.

Bibliography of Zanvil Alexander Cohn

1952

1. Cohn, Z.A. 1952. Quantitative distribution of phosphorus
in chorioallantoic membrane as affected by infection with
influenza virus. Proc. Soc. Exp. Biol. Med. 79:566-568.
1957

1958
4. Cohn, Z.A., F.E. Hahn, W. Ceglowski, and F.M. Bozeman. 1958. Unstable nucleic acids o f Rickettsia mooseri.
Science (Wash. DC). 127:282-283.
1959

5. Cohn, Z.A., F.M. Bozeman, J.M. Campbell, J.W.
Humphries, and T.K. Sawyer. 1959. Study on growth of
Rickettsiae. V. Penetration of Rickettsiae tsutsugamushi
into mammalian cells in vitro.J. Exp. Med. 109:271-292.
6. Cohn, Z.A., and S.I. Morse. 1959. Interactions between
rabbit polymorphonuclear leucocytes and staphylococci.
J. Exp. Med. 110:419-443.
1960

7. Cohn, Z.A. 1960. Relation of cell metabolism to infection
with rickettsial and bacterial agents. Bacteriol. Rev. 24:96-105.
8. Hahn, F.E., Z.A. Cohn, and F.M. Bozeman. 1960. Metabolic studies of rickettsiae. V. Metabolism of glutamine
and asparagine in Rickettsia mooseri.J. Bacteriol. 80:400-405.
9. Cohn, Z.A., and S.I. Morse. 1960. Functional and metabolic properties ofpolymorphonuclear leucocytes. I. O b servations on the requirements and consequences of particle ingestion. J. Exp. Med. 111:667-687.
10. Cohn, Z.A., and S.I. Morse. 1960. Functional and metabolic properties ofpolymorphonuclear leucocytes, lI. The
influence ofa lipopolysaccharide endotoxin.J. Exp. Med.
111:689-704.
11. Cohn, Z.A., andJ.G. Hirsch. 1960. The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes. J. Exp. Med. 112:983-1004.
17

The Editors

1961

14. Hirsch,J.G., Z.A. Cohn, S.I. Morse, R.W. Schaedler, L.E.
Siltzbach, J.T. Ellis, and M.W. Chase. 1961. Evaluation of
the Kveirn reaction as a diagnostic test for sarcoidosis.
N. Engl. J. Med. 265:827-830.
15. Morse, S.I., Z.A. Cohn, J.G. Hirsch, and R.W. Schaedler.
1961. The treatment ofsarcoidosis with chloroquine. Am.
J. Med. 30:779-784.

1962

16. Cohn, Z.A. 1962. Determinants of infection in the peritoneal cavity. I. Response to and fate of Staphylococcus aureus
and Staphylococcus albus in the mouse. YaleJ. Biol. Mecl.
35:12-28.
17. Cohn, Z.A. 1962. Determinants of infection in the peritoneal cavity. II. Factors influencing the fate of Staphylococcus aureus in the mouse. YaleJ. Biol. Med. 35:29-47.
18. Cohn, Z.A. 1962. Determinants of infection in the peritoneal cavity. III. The action of selected inhibitors on the
fate of Staphylococcus aureus in the mouse. YaleJ. Biol. Med.
35:48-61.
19. Cohn, Z.A. 1962. Influence of rabbit polymorphonuclear
leucocytes and macrophages on the immunogenicity of
Escherichia coli. Nature (Lond.). 196:1066-1068.

1963

20. Austen, K.F., and Z.A. Cohn. 1963. Contribution of serum
and cellular factors in host defense reactions. I. Serum factors in host resistance. N. Engl.J. Med. 268:933-938 and
994-1000.
21. Cohn, Z.A., and K.F. Austen. 1963. Contribution of serum
and cellular factors in host defense reactions. II. Cellular
factors in host resistance. N. Engl.J. Med. 268:1056-1064.
22. Cohn, Z.A. 1963. The fate of bacteria within phagocytic
cells. I. The degradation of isotopically labeled bacteria
by polymorphonuclear leucocytes and macrophages.J. Exp.
Med. 117:27-42.
23. Cohn, Z.A. 1963. The fate of bacteria within phagocytic

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

2. Hayes, J.E., F.E. Hahn, Z.A. Cohn, E.B.Jackson, andJ.E.
Smadel. 1957. Metabolic studies o f rickettsiae. IV. Terminal respiratory enzymes in Rickettsia mooseri. Biochim.
Biophys. Acta. 26:570-576.
3. Schaechter, M., A.J. Tousimis, Z.A. Cohn, H. Rosen,
J. Campbell, and F.E. Hahn. 1957. Morphological, chemical, and serological studies of the cell walls of Rickettsia
mooseri. J. Bacteriol. 74:822-829.

12. Hirsch,J.G., and Z.A. Cohn. 1960. Degranulation ofpolymorphonuclear leucocytes following phagocytosis of microorganisms. J. Exp. Med. 112:1005-1014.
13. Cohn, Z.A., andJ.G. Hirsch. 1960. The influence ofphagocytosis on the intracellular distribution of granule-associated
components ofpolymorphonuclear leucocytes.J. Exp. Med.
112:1015-1022.

24.

25.

26.

27.

1964

28. Cohn, Z.A. 1964. The fate of bacteria within phagocytic
cells. Ill. Destruction of an Escherichia coli agglutinogen
within polymorphonuclear leucocytes and macrophages.
J. Exp. Med. 120:869-883.
29. Hirsch, J.G., and Z.A. Cohn. 1964. Digestive and autolytic functions oflysosomes in phagocytic cells. Fed. Proc.
23:1023-1025.
1965

30. Cohn, Z.A., and B. Benson. 1965. The differentiation of
mononuclear phagocytes. Morphology, cytochemistry, and
biochemistry. J. Exp. Med. 121:153-170.
31. Cohn, Z.A., and B. Benson. 1965. The in vitro differentiation of mononuclear phagocytes. I. The influence of
inhibitors and the results ofautoradiography.J. Exp. Med.
121:279-288.
32. Cohn, Z.A., and B. Benson. 1965. The in vitro differentiation of mononuclear phagocytes. II. The influence of
serum on granule formation, hydrolase production, and
pinocytosis. J. Exp. Med. 121:835-848.
33. Cohn, Z.A., and B. Benson. 1965. The in vitro differentiation of mononuclear phagocytes. III. The reversibility
of granule and hydrolytic enzyme formation and the turnover of granule constituents. J. Exp. Med. 122:455-466.
34. Cohn, Z.A. 1965. The metabolism and physiology of the
mononuclear phagocytes. In The Inflammatory Process.
B.W. Zweifach, L. Grant, and R.T. McCluskey, editors.
Academic Press, New York. 323-353.
35. Cohn, Z.A., and J.G. Hirsch. 1965. Phagocytic cells. In
Bacterial and Mycotic Infections of Man. 4th Ed. RJ.
Dubos andJ.G. Hirsch, editors. J.B. Lippincott Co., Philadelphia. 215-236.
1966

36. Bennett, W.E., and Z.A. Cohn. 1966. The isolation and
selected properties of blood monocytes.J. Exp. Med. 123:
145-159.
18

Tributeto Zanvil Alexander Cohn

37. Cohn, Z.A., J.G. Hirsch, and M.E. Fedorko. 1966. The
in vitro differentiation of mononuclear phagocytes. IV.
The ultrastructure of macrophage differentiation in the
peritoneal cavity and in culture.J. Exp. Med. 123:747-756.
38. Cohn, Z.A., M.E. Fedorko, and J.G. Hirsch. 1966. The
in vitro differentiation ofmononuclear phagocytes. V. The
formation of macrophage lysosomes. J. Exp. Med. 123:
757-766.
39. Cohn, Z.A. 1966. The regulation ofpinocytosis in mouse
macrophages. I. Metabolic requirements as defined by the
use of inhibitors. J. Exp. Med. 124:557-571.

1967

40. Cohn, Z.A., and E. Parks. 1967. The regulation of pinocytosis in mouse macrophages. II. Factors inducing vesicle
formation. J. Exp. Med. 125:213-232.
41. Cohn, Z.A., and E. Parks. 1967. The regulation ofpinocytosis in mouse macrophages. III. The induction of vesicle formation by nucleosides and nucleotides.J. Exp. Med.
125:457-466.
42. Cohn, Z.A., and E. Parks. 1967. The regulation ofpinocytosis in mouse macrophages. IV. The immunological
induction ofpinocytic vesicles, secondary lysosomes, and
hydrolytic enzymes. J. Exp. Med. 125:1091-1104.
43. Ehrenreich, B.A., and Z.A. Cohn. 1967. The uptake and
digestion of iodinated human serum albumin by macrophages in vitro. J. Exp. Med. 126:941-958.
44. Cohn, Z.A., M.E. Fedorko, J.G. Hirsch, S.I. Morse, and
L.E. Sikzbach. 1967. The distribution of Kveim activity
in subcellular fractions from sarcoid lymph nodes. In La
SarcoYdose. J. TuriafandJ. Chabot, editors. Masson, Paris.
141-149.
1968

45. Cohn, Z.A. 1968. The differentiation ofmacrophages. In
Differentiation and Immunology, K.B. Warren, editor. Academic Press, New York. 101-110.
46. Cohn, Z.A. 1968. The structure and function of monocytes and macrophages. In Advances in Immunology. Vol. 9.
F. Dixon and H.G. Kunkel, editors. Academic Press, New
York. 163-214.
47. Ehrenreich, B.A., and Z.A. Cohn. 1968. Fate of hemoglobin pincytosed (sic) by macrophages in vitro. J. Cell
Biol. 38:244-248.
48. Ehrenreich, B.A., and Z.A. Cohn. 1968. Pinocytosis by
macrophages. J. Reticuloendothel. Soc. 5:230-242.
49. Fedorko, M.E., J.G. Hirsch, and Z.A. Cohn. 1968. Autophagic vacuoles produced in vitro. I. Studies on cultured
macrophages exposed to chloroquine. J. Cell Biol. 38:
377-391.
50. Fedorko, M.E., J.G. Hirsch, and Z.A. Cohn. 1968. Autophagic vacuoles produced in vitro. II. Studies on the mechanism of formation of autophagic vacuoles produced by
chloroquine. J. Cell Biol. 38:392-402.
51. Hirsch,J.G., M.E. Fedorko, and Z.A. Cohn. 1968. Vesicle

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

cells. II. The modification of intracellular degradation.
J. Exp. Med. 117:43-53.
Cohn, Z.A., and E. Wiener. 1963. The particulate hydrolases of macrophages. I. Comparative enzymology, isolation, and properties. J. Exp. Med. 118:991-1008.
Cohn, Z.A., and E. Wiener. 1963. The particulate hydrolases ofmacrophages. II. Biochemical and morphological
response to particle ingestion.J. Exp. Med. 118:1009-1020.
Cohn, Z.A.,J.G. Hirsch, and E. Wiener. 1963. The cytoplasmic granules of phagocytic cells and the degradation
of bacteria. In Ciba Foundation Symposium on Lysosomes.
A.V.S. de Rueck and M.P. Cameron, editors. J. & A. Churchill, Ltd., London. 126--144.
Hirsch, J.G., and Z.A. Cohn. 1963. Leucocyte lysosomes.
In Cell-bound Antibodies. B. Amos and H. Koprowski,
editors. Wistar Institute Press, Philadelphia. 45-49.

fusion and formation at the surface ofpinocytic vacuoles
in macrophages. J. Cell Biol. 38:629-632.
52. Hawrylko, E.A., and Z.A. Cohn. 1968. The localization
and origin of carbohydrate-protein complexes in macrophages. Lab. Invest. 19:421-427.
53. van Furth, R., and Z.A. Cohn. 1968. The origin and
kinetics of mononuclear phagocytes. J. Exp. Med. 128:
415-435.

66.

67.

68.
1969

1970

59. AMine, S.G., and Z.A. Cohn. 1970. In vitro induction of
lysosomal enzymes by phagocytosis. J. Exp. Med. 131:
1239-1260.
60. Cohn, Z.A. 1970. Lysosomes in mononuclear phagocytes.
In Mononuclear Phagocytes. R. van Furth, editor. Blackwell Scientific Publications Ltd., Oxford. 50-61.
61. Cohn, Z.A. 1970. Endocytosis and intracellular digestion.
In Mononuclear Phagocytes. R. van Furth, editor. Blackwell Scientific Publications Ltd., Oxford. 121-132.
62. Cohn, Z.A. 1970. Recent studies on the structure and function of leucocytes and macrophages. In Blood Cells as a
Tissue. W.L. Holmes, editor. Plenum Publishing Corporation, New York. 151-156.
63. Gordon, S., and Z. Cohn. 1970. Macrophage-melanocyte
heterokaryons. I. Preparation and properties.J. Exp. Med.
131:981-1003.

1971

64. Gordon, S., and Z. Cohn. 1971. Macrophage-melanocyte
heterokaryons. II. The activation of macrophage DNA
synthesis. Studies with inhibitors ofRNA synthesis.J. Exp.
Med. 133:321-338.
65. Gordon, S., and Z. Cohn. 1971. Macrophage-melanoma
cell heterokaryons. III. The activation ofmacrophage DNA
synthesis. Studies with inhibitors of protein synthesis and
19

The Editors

69.

70.

1972

71. Werb, Z., and Z.A. Cohn. 1972. Cholesterol metabolism
in the macrophage. III. Ingestion and intracellular fate of
cholesterol and cholesterol esters.J. Exp. Med. 135:21-44.
72. Cohn, Z.A. 1972. Some aspects ofmacrophage membranes.
In Inflammation: Mechanisms and Control. I.H. Lepow
and P.A. Ward, editors. Academic Press, New York. 71-81.
73. Cohn, Z.A. 1972. Properties of macrophages. In Phagocytic Mechanisms in Health and Disease. R.C. Williams,
Jr. and H.H. Fudenberg, editors. Intercontinental Medical
Book Corp., New York. 39-49.
74. Holland, P., N.H. Holland, and Z.A. Cohn. 1972. The
selective inhibition of macrophage phagocytic receptors
by anti-membrane antibodies. J. Exp. Med. 135:458-475.
75. Hubbard, A.L., and Z.A. Cohn. 1972. The enzymatic iodination of the red cell membrane.J. Cell Biol. 55:390-405.
76. Steinman, R.M., and Z.A. Cohn. 1972. The interaction
of soluble horseradish peroxidase with mouse peritoneal
macrophages in vitro. J. Cell Biol. 55:186-204.
77. Steinman, R.M., and Z.A. Cohn. 1972. The interaction
of particulate horseradish peroxidase (HRP)-anti HRP immune complexes with mouse peritoneal macrophages in
vitro. J. Cell Biol. 55:616-634.
78. van Furth, R., Z.A. Cohn, J.G. Hirsch, J.H. Humphrey,
W.G. Spector, and H.L. Langevoort. 1972. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull. W. H. O.
46:845-852 (French edition: 47:651-658).
79. Werb, Z., and Z.A. Cohn. 1972. Plasma membrane synthesis in the macrophage following phagocytosis of polystyrene latex particles. J. Biol. Chem. 247:2439-2446.
1973

80. Cohn, Z.A. 1973. IntraceUular digestion. In 'Non-Specific'
Factors Influencing Host Resistance. W. Braun, N.J. Ungar,
and J. Ungar, editors. S. Karger AG, Basel. 143-152.

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

54. Cohn, Z.A., and M.E. Fedorko. 1969. The formation and
fate oflysosomes. In Lysosomes in Biology and Pathology.
J. Dingle, H. Fell, and R. Dean, editors. North-Holland,
Amsterdam. 43-63.
55. Cohn, Z.A. 1969. The requirements and consequences
ofpinocytosis in mouse macrophages. In Cellular Recognition. R.T. Smith and R.A. Good, editors. AppletonCentury-Crofts, New York. 39-45.
56. Cohn, Z.A. 1969. The properties ofmononuclear phagocytes. In Hemic Cells In Vitro. P. Farnes, editor. Williams
& Wilkins Co., Baltimore. 59-63.
57. Cohn, Z.A., and B.A. Ehrenreich. 1969. The uptake, storage, and intracellular hydrolysis of carbohydrates by macrophages. J. Exp. Med. 129:201-225.
58. Ehrenreich, B.A., and Z.A. Cohn. 1969. The fate of peptides pinocytosed by macrophages in vitro. J. Exp. Med.
129:227-245.

with synchronized melanoma cells.J. Exp. Med. 134:935946.
Gordon, S., and Z. Cohn. 1971. Macrophage-melanoma
cell heterokaryons. IV. Unmasking the macrophage-specific
membrane receptor. J. Exp. Med. 134:947-962.
Gordon, S., C.S. Ripps, and Z. Cohn. 1971. The preparation and properties ofmacrophage-L cell hybrids.J. Exp.
Med. 134:1187-1200.
Cohn, Z.A. 1971. Endocytosis and the vacuolar system.
In Cell Membranes: Biological and Pathological Aspects.
G.W. Richter and D.G. Scarpelli, editors. Williams &
Wilkins Co., Baltimore. 129-135.
Werb, Z., and Z.A. Cohn. 1971. Cholesterol metabolism
in the macrophage. I. The regulation of cholesterol exchange. J. Exp. Med. 134:1545-1569.
Werb, Z., and Z.A. Cohn. 1971. Cholesterol metabolism
in the macrophage. II. Alteration ofsubcellular exchangeable cholesterol compartments and exchange in other cell
types. J. Exp. Med. 134:1570-1590.

81. Edelson, PJ., and Z.A. Cohn. 1973. Peroxidase-mediated
mammalian cell cytotoxicity. J. Exp. Med. 138:318-323.
82. Gordon, S., and Z.A. Cohn. 1973. The macrophage. Int.
Rev. Cytot. 36:171-214.
83. Seljelid, R., S.C. Silverstein, and Z.A. Cohn. 1973. The
effect of poly-L-lysine on the uptake of reovirus doublestranded RNA in macrophages in vitro. J. Cell Biol.
57:484-498.
84. Steinman, R.M., and Z.A. Cohn. 1973. Identification of
a novel cell type in peripheral lymphoid organs of mice.
I. Morphology, quantitation, tissue distribution. J. Exp.
Med. 137:1142-1162.

85. Cohn, Z.A., and Z. Werb. 1974. The preparation of macrophage lysosomes and phagolysosomes. Methods Enzymol.
31:339-345.
86. Cohn, Z.A. 1974. The isolation and cultivation ofmononuclear phagocytes. Methods Enzymol. 32:758-765.
87. Edelson, P.J., and Z.A. Cohn. 1974. Effects ofconcanavalin A on mouse peritoneal macrophages. I. Stimulation
of endocytic activity and inhibition of phago-lysosome
formation. J. Exp. Med. 140:1364-1386.
88. Edelson, P.J., and Z.A. Cohn. 1974. Effects ofconcanavalin A on mouse peritoneal macrophages. II. Metabolism
of endocytized proteins and reversibility of the effects by
mannose. J. Exp. Med. 140:1387-1403.
89. Gordon, S., J. Todd, and Z.A. Cohn. 1974. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J. Exp. Med. 139:1228-1248.
90. Gordon, S., J.C. Unkeless, and Z.A. Cohn. 1974. Induction of macrophage plasminogen activator by endotoxin
stimulation and phagocytosis. Evidence for a two-stage
process. J. Exp. Med. 140:995-1010.
91. Steinman, R.M., and Z.A. Cohn. 1974. Identification of
a novel cell type in peripheral lymphoid organs of mice.
II. Functional properties in vitro. J. Exp. Med. 139:
380-397.
92. Steinman, R.M., D.S. Lustig, and Z.A. Cohn. 1974. Identification of a novel cell type in peripheral lymphoid organs
of mice. III. Functional properties in vivo. J. Exp. Med.
139:1431-1445.
93. Steinman, R.M.,J.M. Silver, and Z.A. Cohn. 1974. Pinocytosis in fibroblasts. Quantitative studies in vitro. J. Cell
Biol. 63:949-969.
94. Steinman, R.M., and Z.A. Cohn. 1974. The metabolism
and physiology of the mononuclear phagocytes. In The
Inflammatory Process. Vol. 1, 2nd Ed. B.W. Zweifach,
L. Grant, and R.T. McCluskey, editors. Academic Press,
New York. 449-510.
1975

95. Cohn, Z.A. 1975. Macrophage physiology. Fed. Proc. 34:
1725-1729.

20

Tributeto Zanvil Alexander Cohn

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

1974

96. Cohn, Z.A. 1975. Mechanisms of host resistance. In New
Approaches for Inducing Natural Immunity to Pyogenic
Organisms. J.B. Robbins, R.E. Horton, and R.M. Krause,
editors. Department of Health, Education, and Welfare
Publication 74-553, Washington, DC. 4-9.
97. Cohn, Z.A. 1975. The saga of the macrophage. In Immune Recognition. A.S. Rosenthal, editor. Academic
Press, New York. 537-538.
98. Cohn, Z.A. 1975. Recent studies on the physiology of
cultivated macrophages. In The Phagocytic Cell in Host
Resistance. J.A. Bellanti and D.H. Dayton, editors. Raven
Press, Ltd., New York. 15-24.
99. Cohn, Z.A. 1975. The role ofproteases in macrophage
physiology. In Proteases and Biological Control Cold
Spring Harbor Laboratory, Cold Spring Harbor, NY.
483-493.
100. Edelson, PJ., R. Zwiebel, and Z.A. Cohn. 1975. The
pinocytic rate of activated macrophages. J. Exp. Med.
142:1150--1164.
101. Gordon, S., J.C. Unkeless, and Z.A. Cohn. 1975. The
macrophage as secretory cell. In Immune Recognition.
A.S. Rosenthal, editor. Academic Press, New York.
589-614.
102. Hubbard, A.L., and Z.A. Cohn. 1975. Externally disposed
plasma membrane proteins. I. Enzymatic iodination of
mouse L cells. J. Cell Biol. 64:438-460.
103. Hubbard, A.L., and Z.A. Cohn. 1975. Externally disposed
plasma membrane proteins. II. Metabolic fate ofiodinated
polypeptides of mouse L cells. J. Celt Biol. 64:461-479.
104. Nogueira, N., C. Bianco, and Z. Cohn. 1975. Studies
on the selective lysis and purification of Trypanosoma cruzi.
J. Exp. Med. 142:224-229.
105. Steinman, R.M.,J.C. Adams, and Z.A. Cohn. 1975. Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse
spleen. J. Exp. Med. 141:804-820.
106. Steinman, R.M., and Z.A. Cohn. 1975. A novel adherent
cell in mouse lymphoid organs. In Immune Recognition.
A.S. Rosenthal, editor. Academic Press, New York. 571587.
107. Steinman, R.M., and A. Cohn (sic). 1975. Dendritic cells,
reticular cells, and macrophages. In Mononuclear Phagocytes in Immunity, Infection, and Pathology. R. van Furth,
editor. Blackwell Scientific Publications Ltd., Oxford.
95-109.
108. Steinman, R.M., and Z.A. Cohn. 1975.Binding of soluble
proteins and particulate immune complexes to macrophages. In Mononuclear Phagocytes in Immunity, Infection, and Pathology. R. van Furth, editor. Blackwell Scientific Publications Ltd., Oxford. 743-754.
109. Cohn, Z.A. 1975. Summing up. In Mononuclear Phagocytes in Immunity, Infection, and Pathology. R. van Furth,
editor. Blackwell Scientific Publications Ltd., Oxford.
1037-1045.

1978

110. Bianco, C., A. Eden, and Z.A. Cohn. 1976. The induction ofmacrophage spreading: role of coagulation factors
and the complement system.J. Exp. Med. 144:1531-1544.
111. Cohn, Z.A. 1976. Introduction. In Immunobiology of
the Macrophage. D.S. Nelson, editor. Academic Press,
New York. xvii-xviii.
112. Edelson, P.J., and Z.A. Cohn. 1976. 5'-Nucleotidase
activity of mouse peritoneal macrophages. I. Synthesis
and degradation in resident and inflammatory populations.
J. Exp. Med. 144:1581-1595.
113. Edelson, P.J., and Z.A. Cohn. 1976. 5'-Nucleotidase
activity of mouse peritoneal macrophages. II. Cellular
distribution and effects ofendocytosis.J. Exp. Med. 144:
1596-1608.
114. Hubbard, A.L., and Z.A. Cohn. 1976. Specific labels for
cell surfaces. In Biochemical Analysis of Membranes. A.H.
Maddy, editor. Chapman and Hall Ltd., London. 427501.
115. Nogueira, N., and Z.A. Cohn. 1976. Trypanosoma cruzi:
mechanism of entry and intracellular fate in mammalian
cells. J. Exp. Med. 143:1402-1420.
116. Steinman, R.M., and Z.A. Cohn. 1976. Endocytosis and
the vacuolar apparatus. In Biogenesis and Turnover of
Membrane Macromolecules. J.S. Cook, editor. Raven
Press, Ltd., New York. 1-14.
117. Steinman, R.M., S.E. Brodie, and Z.A. Cohn. 1976. Membrane flow during pinocytosis. A stereologic analysis.
J. Cell Biol. 68:665-687.
118. Stossel, T.E, and Z.A. Cohn. 1976. Phagocytosis. Methods Immunol. Immunochem. 5:261-296.

126. Cohn, Z.A. 1978. The activation ofmononuclear phagocytes: facts, fancy, and future. J. Immunol. 121:813-816.
127. Cohn, Z.A. 1978. The role ofmacrophages in infectious
processes. In The Infection-Prone Hospital Patient. J.F.
Burke and G.Y. Hildick-Smith, editors. Little Brown and
Company, Boston. 17-24.
128. Cohn, Z.A. 1978. The maturation and activation ofmononuclear phagocytes. In Differentiation of Normal and
Neoplastic Hematopoietic Cells. B. ClarEson, P.A. MarEs,
and J.E. Till, editors. Cold Spring Harbor Laboratory,
Cold Spring Harbor, NY. 383-392.
129. Gordon, S., and Z.A. Cohn. 1978. Bacille CalmetteGu~rin infection in the mouse. Regulation ofmacrophage
plasminogen activator by T lymphocytes and specific
antigen. J. Exp. Med. 147:1175-1188.
130. Johnston, R.B.,Jr., C.A. Godzik, and Z.A. Cohn. 1978.
Increased superoxide anion production by immunologically activated and chemically elicited macrophages.
J. Exp. Med. 148:115-127.
131. Nogueira, N., and Z.A. Cohn. 1978. Trypanosoma cruzi:
in vitro induction of macrophage microbicidal activity.
J. Exp. Med. 148:288-300.
132. Steinman, R.M., B.G. Machtinger, J. Fried, and Z.A.
Cohn. 1978. Mouse spleen lymphoblasts generated in vitro.
Recovery in high yield and purity after floatation in dense
bovine plasma albumin solutions.J. Exp. Med. 147:279296.
133. Steinman, R.M., S.J. Blumencranz, B.G. Machtinger,
J. Fried, and Z.A. Cohn. 1978. Mouse spleen lymphoblasts generated in vitro. Their replication and differentiation in vitro. J. Exp. Med. 147:297-315.
134. Steinman, R.M.,J.M. Silver, and Z.A. Cohn. 1978. Fluid
phase pinocytosis. In Transport of Macromolecules in
Cellular Systems. S.C. Silverstein, editor. Dahlem Konferenzen, Berlin. 167-180.
135. Tuan, R.S., W.A. Scott, and Z.A. Cohn. 1978. Calciumbinding protein of the chick chorioallantoic membrane.
I. Immunohistochemical localization.J. Cell Biol. 77:743751.
136. Tuan, R.S., W.A. Scott, and Z.A. Cohn. 1978. Calciumbinding protein of the chick chorioallantoic membrane. II.
Vitamin K-dependent expression.J. Cell Biol. 77:752-761.
137. Tuan, R.S., W.A. Scott, and Z.A. Cohn. 1978. Purification and characterization of calcium-binding protein from
chick chorioallantoic membrane. J. Biol. Chem. 253:
1011-1016.

1977
119. Cohn, Z.A. 1977. Physiology and biochemistry of phagocytic cells. In Frontiers of Medicine. G.M. Meade, editor.
Plenum Publishing Corporation, New York. 95-104.
120. Johnson, W.D., Jr., B. Mei, and Z.A. Cohn. 1977. The
separation, long-term cultivation, and maturation of the
human monocyte. J. Exp. Med. 146:1613-1626.
121. Mahoney, E.M., A.L. Hamill, W.A. Scott, and Z.A.
Cohn. 1977. Response ofendocytosis to altered fatty acyl
composition of macrophage phospholipids. Proc. Natl.
Acad. Sci. USA. 74:4895-4899.
122. Nogueira, N., and Z. Cohn. 1977. Trypanosomacruzi: uptake and intracellular fate in normal and activated cells.
Am. J. Trop. Med. Hyg. 26:194-203.
123. Nogueira, N., S. Gordon, and Z. Cohn. 1977. Trypanosoma cruzi: modification ofmacrophage function during
infection. J. Exp. Med. 146:157-171.
124. Nogueira, N., S. Gordon, and Z. Cohn. 1977. Trypanosoma cruzi: the immunological induction ofmacrophage
plasminogen activator requires thymus-derived lymphocytes. J. Exp. Med. 146:172-183.
125. Silverstein, S.C., R.M. Steinman, and Z.A. Cohn. 1977.
Endocytosis. Annu. Rev. Biochem. 46:669-722.
21

The Editors

1979
138. Bianco, C., O. Grtze, and Z.A. Cohn. 1979. Regulation
of macrophage migration by products of the complement system. Proc. Natl. Acad. Sci. USA. 76:888-891.
139. Grtze, O., C. Bianco, and Z.A. Cohn. 1979. The induction of macrophage spreading by factor B of the properdin system. J. Exp. Med. 149:372-386.

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

1976

1980

151. Aley, S.B., W.A. Scott, and Z.A. Cohn. 1980. Isolation
of the plasma membrane ofentamoeba histolytica. Arch.
Invest. Med. 11:41-45.
152. Aley, S.B., W.A. Scott, and Z.A. Cohn. 1980. Plasma
membrane of Entamoeba histolytica. J. Exp. Med. 152:
391-404.
153. Cohn, Z.A. 1980. The role ofmacrophages in acute and
chronic inflammatory responses. In Streptococcal Diseases
and the Immune Response. S.E. Read andJ.B. Zabriskie,
editors. Academic Press, New York. 271-280.
22

Tributeto Zanvil Alexander Cohn

154. Kielian, M.C., and Z.A. Cohn. 1980. Phagosomelysosome fusion. Characterization of intracellular membrane fusion in mouse macrophages.J. Cell Biol. 85:754765.
155. Mahoney, E.M., W.A. Scott, F.R. Landsberger, A.L.
HamiU, and Z.A. Cohn. 1980. Influence of fatty acyl substitution on the composition and function ofmacrophage
membranes. J. Biol. Chem. 255:4910-4917.
156. Mellman, I.S., R.M. Steinman, J.C. Unkeless, and Z.A.
Cohn. 1980. Selective iodination and polypeptide composition of pinocytic vesicles. J. Cell Biol. 86:712-722.
157. Muller, W.A., R.M. Steinman, and Z.A. Cohn. 1980.
The membrane proteins of the vacuolar system. I. Analysis by a novel method ofintralysosomal iodination.J. Cell
Biol. 86:292-303.
158. Muller, W.A., R.M. Steinman, and Z.A. Cohn. 1980.
The membrane proteins of the vacuolar system. II. Bidirectional flow between secondary lysosomes and plasma
membrane. J. Cell Biol. 86:304-314.
159. Murray, H.W., and Z.A. Cohn. 1980. Mononuclear
phagocyte antimicrobial and antitumor activity: the role
of oxygen intermediates.J. Invest. Dermatol. 74:285-288.
160. Murray, H.W., and Z.A. Cohn. 1980. Macrophage
oxygen-dependent antimicrobial activity. III. Enhanced
oxidative metabolism as an expression ofmacrophage activation. J. Exp. Med. 152:1596-1609.
161. Murray, H.W., C.F. Nathan, and Z.A. Cohn. 1980.
Macrophage oxygen-dependent antimicrobial activity.
IV. Role of endogenous scavengers of oxygen intermediates. J. Exp. Med. 152:1610-1624.
162. Nathan, C., L. Brukner, G. Kaplan, J. Unkeless, and Z.
Cohn. 1980. Role of activated macrophages in antibodydependent lysis of tumor cells. J. Exp. Med. 152:183197.
163. Nathan, C., and Z. Cohn. 1980. Role of oxygendependent mechanisms in antibody-induced lysis ofturnor
cells by activated macrophages. J. Exp. Med. 152:198208.
164. Nathan, C.F., H.W. Murray, and Z.A. Cohn. 1980. The
macrophage as an effector cell. N. Engl. J. Med. 303:
622-626.
165. Nogueira, N., S. Chaplan, and Z. Cohn. 1980. Trypanosoma cruzi: factors modifying ingestion and fate of blood
form trypomastigotes. J. Exp. Med. 152:447-451.
166. Nussenzweig, M.C., R.M. Steinman, B. Gutchinov, and
Z.A. Cohn. 1980. Dendritic cells are accessory cells for
the development of anti-trinitrophenyl cytotoxic T
lymphocytes. J. Exp. Med. 152:1070-1084.
167. Rouzer, C.A., W.A. Scott, A.L. Hamill, and Z.A. Cohn.
1980. Dynamics ofleukotriene C production by macrophages. J. Exp. Med. 152:1236-1247.
168. Rouzer, C.A., W.A. Scott, J. Kempe, and Z.A. Cohn.
1980. Prostaglandin synthesis by macrophages requires
a specific receptor-ligand interaction. Proc. Natl. Acad.
Sci. USA. 77:4279-4282.
169. Rouzer, C.A., W.A. Scott, Z.A. Cohn, P. Blackburn, and
J.M. Manning. 1980. Mouse peritoneal macrophages re-

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

140. Kaplan, G., J.C. Unkeless, and Z.A. Cohn. 1979. Insertion and turnover ofmacrophage plasma membrane proteins. Proc. Natl. Acad. Sci. USA. 76:3824-3828.
141. Murray, H.W., and Z.A. Cohn. 1979. Macrophage
oxygen-dependent antimicrobiaI activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates. J. Exp.
Med. 150:938-949.
142. Murray, H.W., C.W.Juangbhanich, C.F. Nathan, and Z.A.
Cohn. 1979. Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates.J. Exp.
Med. 150:950-964.
143. Murray, H.W., and Z.A. Cohn. 1979. Activated mononuclear phagocyte functions. INFLO. 12:1 and 3.
144. Nathan, C.F., L.H. Brukner, S.C. Silverstein, and Z.A.
Cohn. 1979. Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of
effector cells and the release of hydrogen peroxide.J. Exp.
Med. 149:84-99.
145. Nathan, C.F., S.C. Silverstein, L.H. Brukner, and Z.A.
Cohn. 1979. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J. Exp. Med. 149:100-113.
146. Nathan, C., N. Nogueira, C. Juangbhanich, J. Ellis, and
Z. Cohn. 1979. Activation ofmacrophages in vivo and in
vitro. Correlation between hydrogen peroxide release and
killing of Trypanosoma cruzi.J. Exp. Med. 149:1056-1068.
147. Nogueira, N., and Z. Cohn. 1979. Trypanosomacruzi: cellmediated immunity in vitro. In Role of the Spleen in the
Immunology of Parasitic Diseases. Schwabe & Co. AG,
Basel. 137-149.
148. Steinman, R.M., G. Kaplan, M.D. Witmer, and Z.A.
Cohn. 1979. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen
dendritic cells, new surface markers, and maintenance
in vitro. J. Exp. Med. 149:1-16.
149. Steinman, R.M., M.D. Witmer, M.C. Nussenzweig, L.L.
Chert, and Z.A. Cohn. 1979. Dendritic cells: an important new cell type in the mixed leukocyte reaction. In
The Molecular Basis of Immune Cell Function. J.G.
Kaplan, editor. Elsevier/North Holland Biomedical Press,
Amsterdam. 273-281.
150. Unkeless, J.C., G. Kaplan, H. Plutner, and Z.A. Cohn.
1979. Fc-receptor variants of a mouse macrophage cell
line. Proc. Natl. Acad. Sci. USA. 76:1400-1404.

170.

171.

172.

174.

175.

176.

177.

178.

179.

180.

181.

23

The Editors

Part I. R. van Furth, editor. Martinus Nijhoff, The Hague.
649-664.
182. Cohn, Z.A. 1980. Summation. In Mononuclear Phagocytes. Functional Aspects. Part II. R. van Furth, editor.
Martinus Nijhoff, The Hague. 1925-1929.

1981
183. Johnston, R.B.,Jr., D.A. Chadwick, and Z.A. Cohn. 1981.
Priming of macrophages for enhanced oxidative metabolism by exposure to proteolytic enzymes. J. Exp. Med.
153:1678-1683.
184. Kielian, M.C., and Z.A. Cohn. 1981. Modulation of
phagosome-lysosome fusion in mouse macrophages. J.
Exp. Med. 153:1015-1020.
185. Kielian, M.C., and Z.A. Cohn. 1981. Phorbol myristate
acetate stimulates phagosome-lysosome fusion in mouse
macrophages. J. Exp. Med. 154:101-111.
186. Nakagawara, A., C.F. Nathan, and Z.A. Cohn. 1981.
Hydrogen peroxide metabolism in human monocytes
during differentiation in vitro. J. Clin. Invest. 68:12431252.
187. Nathan, C.F., B.A. Arrick, H.W. Murray, N.M. DeSantis,
and Z.A. Cohn. 1981. Tumor cell anti-oxidant defenses:
inhibition of the glutathione redox cycle enhances
macrophage-mediated cytolysis.J. Exp. Med. 153:766-782.
188. Nathan, C.F., and Z.A. Cohn. 1981. Antitumor effects
of hydrogen peroxide in vivo.J. Exp. Med. 154:1539-1553.
189. Nathan, C.F., and Z.A. Cohn. 1981. Cellular components
ofinflamrnation: monocytes and macrophages. In Textbook ofRheumatology. Vol. I. W.N. Kelley, E.D. Harris,Jr., S. Ruddy, and C.B. Sledge, editors. W.B. Saunders
Company, Philadelphia. 136-162.
190. Nogueira, N., S. Chaplan, J.D. Tydings, J. Unkeless, and
Z. Cohn. 1981. Trypanosoma cruzi: surface antigens of blood
and culture forms. J. Exp. Med. 153:629-639.
191. Nogueira, N., J. Ellis, S. Chaplan, and Z. Cohn. 1981.
Trypanosoma cruzi: in vivo and in vitro correlation between
T-cell activation and susceptibility in inbred strains of
mice. Exp. Parasitol. 51:325-334.
192. Nussenzweig, M.C., R.M. Steinman, J.C. Unkeless, M.D.
Witmer, B. Gutchinov, and Z.A. Cohn. 1981. Studies
of the cell surface of mouse dendritic cells and other leukocytes. J. Exp. Med. 154:168-187.
193. Rouzer, C.A., W.A. Scott, O.W. Griflith, A.L. Hamill,
and Z.A. Cohn. 1981. Depletion ofglutathione selectively
inhibits synthesis ofleukotriene C by macrophages. Proc.
Natl. Acad. Sci. USA. 78:2532-2536.
194. Mellman, I.S., R.M. Steinman, J.C. Unkeless, and Z.A.
Cohn. 1981. Selective iodination and polypeptide composition of macrophage endocytic vesicles. In Heterogeneity of Mononuclear Phagocytes. O. F6rster and M.
Landy, editors. Academic Press, New York. 110-114.
195. Nathan, C.F., and Z.A. Cohn. 1981. Lysis of alloantiserum-coated lymphoma cells by activated macrophages: contribution of oxygen-dependent mechanisms.
In Heterogeneity of Mononuclear Phagocytes. O. Forster

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

173.

lease leukotriene C in response to a phagocytic stimulus.
Proc. Natl. Acad. Sci. USA. 77:4928--4932.
Scott, W.A.,J.M. Zrike, A.L. Hamill,J. Kempe, and Z.A.
Cohn. 1980. Regulation of arachidonic acid metabolites
in macrophages. J. Exp. Med. 152:324-335.
Steinman, R.M., M.D. Witmer, M.C. Nussenzweig, L.L.
Chen, S. Schlesinger, and Z.A. Cohn. 1980. Dendritic
cells of the mouse: identification and characterization.
J. Invest. Dermatol. 75:14-16.
Steinman, R.M., M.D. Witmer, M.C. Nussenzweig, L.L.
Chen, G. Kaplan, and Z.A. Cohn. 1980. Dendritic cells,
an important new cell type in MHC-linked functions.
In Macrophage Regulation of Immunity. E.R. Unanue
and A.S. Rosenthal, editors. Academic Press, New York.
297-305.
Yin, H.L., S. Aley, C. Bianco, and Z.A. Cohn. 1980.
Plasma membrane polypeptides of resident and activated
mouse peritoneal macrophages. Proc. Natl. Acad. Sci. USA.
77:2188-2191.
Bianco, C., O. G6tze, and Z.A. Cohn. 1980. Complement, coagulation and mononuclear phagocytes. In
Mononuclear Phagocytes. Functional Aspects. Part II.
R. van Furth, editor. Martinus Nijhoff, The Hague.
1443-1466.
G6tze, O., C. Bianco, J.S. Sundsmo, and Z.A. Cohn.
1980. The stimulation of mononuclear phagocytes by
components of the classical and the alternative pathways
of complement activation. In Mononuclear Phagocytes.
Functional Aspects. Part II. R. van Furth, editor. Martinus Nijhoff, The Hague. 1421-1442.
Kielian, M.C., and Z.A. Cohn. 1980. Determinants of
phagosome-lysosome fusion in mouse macrophages. In
Mononuclear Phagocytes. Functional Aspects. Part II.
R. van Furth, editor. Martinus Nijhoff, The Hague.
1077-1102.
Muller, W.A., R.M. Steinman, and Z.A. Cohn. 1980.
Membrane flow during endocytosis. In Mononuclear
Phagocytes. Functional Aspects. Part I. R. van Furth, editor. Martinus Nijhoff, The Hague. 595-612.
Nogueira, N., G. Kaplan, and Z.A. Cohn. 1980. Induction ofmacrophage microbicidal activity. In Mononuclear
Phagocytes. Functional Aspects. Part II. R. van Furth,
editor. Martinus Nijhoff, The Hague. 1587-1610.
Scott, W.A., E.M. Mahoney, and Z.A. Cohn. 1980.
Membrane lipids and the control of endocytosis. In
Mononuclear Phagocytes. Functional Aspects. Part I.
R. van Furth, editor. Martinus Nijhoff, The Hague.
685-703.
Steinman, R.M., L.L. Chen, M.D. Witmer, G. Kaplan,
M.C. Nussenzweig, J.C. Adams, and Z.A. Cohn. 1980.
Dendritic cells and macrophages--current knowledge of
their distinctive properties and functions. In Mononuclear
Phagocytes. Functional Aspects. Part II. R. van Furth,
editor. Martinus Nijhoff, The Hague. 1781-1807.
Yin, H.L., C. Bianco, and Z.A. Cohn. 1980. The iodination and turnover ofmacrophage plasma membrane polypeptides. In Mononuclear Phagocytes. Functional Aspects.

209.

210.

1982

211.

212.

213.

199. Arrick, B.A., C.F. Nathan, O.W. Griffith, and Z.A. Cohn.
1982. Glutathione depletion sensitizes tumor cells to oxidative cytolysis. J. Biol. Chem. 257:1231-1237.
200. Cohn, Z.A., and W.A. Scott. 1982. New roles for the
mononuclear phagocyte. In Self-Defense Mechanisms.
Role ofMacrophages. D. Mizuno, Z.A. Cohn, K. Takeya,
and N. Ishida, editors. University of Tokyo Press, Tokyo.
207-213.
201. Cohn, Z.A., and R.M. Steinman. 1982. Phagocytosis and
fluid-phase pinocytosis. In Membrane Recycling. Ciba
Foundation Symposium 92. D. Evered and G.M. Collins,
editors. Pitman Books Ltd., London. 15-34.
202. Fels, A.O.S., N.A. Pawlowski, E.B. Cramer, T.K.C. King,
Z.A. Cohn, and W.A. Scott. 1982. Human alveolar macrophages produce leukotriene B4. Proc, Natl. Acad. Sci.
USA. 79:7866-7870.
203. Kielian, M.C., R.M. Steinman, and Z.A. Cohn. 1982.
Intralysosomal accumulation of polyanions. I. Fusion of
pinocytic and phagocytic vacuoles with secondary lysosomes. J. Cell Biol. 93:866-874.
204. Kielian, M.C., and Z.A. Cohn. 1982. Intralysosomal accumulation ofpolyanions. II. Polyanion internalization and
its influence on lysosomal pH and membrane fluidity.
J. Cell Biol. 93:875-882.
205. Nogueira, N., J. Unkeless, and Z. Cohn. 1982. Specific
glycoprotein antigens on the surface of insect and mammalian stages of Trypanosoma cruzi. Proc. Natl. Acad. Sci.
USA. 79:1259-1263.
206. Nogueira, N.M., S.J. Klebanoff, and Z.A. Cohn. 1982.
72. cruzi: sensitization to macrophage killing by eosinophil peroxidase. J. Immunol. 128:1705--1708.
207. Nogueira, N., S. Chaplan, M. Reesink, J. Tydings, and
Z.A. Cohn. 1982. Trypanosoma cruzi: induction of microbicidal activity in human mononuclear phagocytes.
J. Immunol. 128:2142-2146.
208. Pawlowski, N.A., W.A. Scott, M. Andreach, and Z.A.
24

Tributeto Zanvil Alexander Cohn

214.

215.

216.

217.

218.

219.

Cohn. 1982. Uptake and metabolism of monohydroxyeicosatetraenoic acids by macrophages.J. Exp. Med. 155:
1653-1664.
Rouzer, C.A., W.A. Scott, O.W. Griffith, A.L. Hamill,
and Z.A. Cohn. 1982. Arachidonic acid metabolism in
glutathione-deficient macrophages. Proc. Natl. Acad. Sci.
USA. 79:1621-1625.
Rouzer, C.A., W.A. Scott, A.L. Hamill, F.-T. Liu, D.H.
Katz, and Z.A. Cohn. 1982. IgE immune complexes
stimulate arachidonic acid release by mouse peritoneal
macrophages. Proc. Natl. Acad. Sci. USA. 79:5656-5660.
Rouzer, C.A., W.A. Scott, A.L. Hamill, and Z.A. Cohn.
1982. Synthesis of leukotriene C and other arachidonic
acid metabolites by mouse pulmonary macrophages.
J. Exp. Med. 155:720-733.
Rouzer, C.A., W.A. Scott, A.L. Hamill, F.-T. Liu, D.H.
Katz, and Z.A. Cohn. 1982. Secretion ofleukotriene C
and other arachidonic acid metabolites by macrophages
challenged with immunoglobulin E immune complexes.
J. Exp. Med. 156:1077-1086.
Rouzer, C.A., W.A. Scott, O.W. Griffith, A.L. Hamill,
and Z.A. Cohn. 1982. Glutathione metabolism in resting
and phagocytizing peritoneal macrophages.J. Biol. Chem.
257:2002-2008.
Scott, W.A., N.A. Pawlowski, M. Andreach, and Z.A.
Cohn. 1982. Resting macrophages produce distinct metabolites from exogenous arachidonic acid. J. Exp. Med.
155:535-547.
Scott, W.A., N.A. Pawlowski, H.W. Murray, M. Andreach, J. Zrike, and Z.A. Cohn. 1982. Regulation of
arachidonic acid metabolism by macrophage activation.
J. Exp. Med. 155:1148-1160.
Scott, W.A., and Z.A. Cohn. 1982. Secretory products
ofmononuclear phagocytes. In Pathobiology of the Endothelial Cell. H.L. Nossel and H.J. Vogel, editors. Academic Press, New York. 351-356.
Steinman, R.M., M.C. Nussenzweig, J.M. Austyn, M.D.
Witmer, B. Gutchinov, J.C. Unkeless, and Z.A. Cohn.
1982. Monoclonal antibody studies of mouse dendritic
cells and macrophages. In Self-Defense Mechanisms. Role
ofMacrophages. D. Mizuno, Z.A. Cohn, K. Takeya, and
N. Ishida, editors. University of Tokyo Press, Tokyo.
103-109.
Van Voorhis, W.C., G. Kaplan, E.N. Sarno, M.A. Horwitz, R.M. Steinman, W.R. Levis, N. Nogueira, L.S. Hair,
C.R. Gattass, B.A. Arrick, and Z.A. Cohn. t982. The
cutaneous infiltrates of leprosy. Cellular characteristics
and the predominant T-cell phenotypes. N. EngI.J. Mecl.
307:1593-1597.
Young, J.D.-E, T.M. Young, L.P. Lu, J.C. Unkeless, and
Z.A. Cohn. 1982. Characterization of a membrane poreforming protein from Entamoeba histolytica.J. Exp. Med.
156:1677-1690.

1983
220. Arrick, B.A., C.F. Nathan, and Z.A. Cohn. 1983. Inhibition of glutathione synthesis augments lysis of murine

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

and M. Landy, editors. Academic Press, New York.
315-323.
196. Rouzer, C.A., W.A. Scott, J. Kempe, and Z.A. Cohn.
1981. Role of specific receptor-ligand interactions in the
stimulation of prostaglandin synthesis by macrophages.
In Heterogeneity of Mononuclear Phagocytes. O. Forster
and M. Landy, editors. Academic Press, New York. 253256.
197. Rouzer, C.A., W.A. Scott, Z.A. Cohn, P. Blackburn, and
J.M. Manning. 1981. Production of leukotriene C by
mouse macrophages. In Heterogeneity of Mononuclear
Phagocytes. O. Forster and M. Landy, editors. Academic
Press, New York. 296-297.
198. Steinman, R.M., M.C. Nussenzweig, M.D. Witmer, N.
Nogueira, and Z.A. Cohn. 1981. A comparison of dendritic cells and macrophages. In Heterogeneity of Mononuclear Phagocytes. O. Forster and M. Landy, editors.
Academic Press, New York. 189-194.

221.

222.

223.

224.

226.

227.

228.

229.

230.
231.

232.

233.

234.

25

The Editors

Fc receptor as ligand-dependent ion channel. Nature
(Lond.). 306:186-189.
235. Young, J.D.-E, J.C. Unkeless, H.R. Kaback, and Z.A.
Cohn. 1983. Macrophage membrane potential changes
associated with y2b/71 Fc receptor-ligand binding. Proc.
Natl. Acad. Sci. USA. 80:1357-1361.
236. Young, J.D.-E, J.C. Unkeless, H.R. Kaback, and Z.A.
Cohn. 1983. Mouse macrophage Fc receptor for IgG
3,2b/3'1 in artificial and plasma membrane vesicles functions as a ligand-dependent ionophore. Proc. Natl. Acad.
Sci. USA. 80:1636-1640.
237. Young, J.D.-E, M. Blake, A. Mauro, and Z.A. Cohn.
1983. Properties of the major outer membrane protein
from Neisseria gonorrhoeae incorporated into model lipid
membranes. Proc. Natl. Acad. Sci. USA. 80:3831-3835.

1984

238. Aderem, A.A., W.A. Scott, and Z.A. Cohn. 1984. A selective defect in arachidonic acid release from macrophage
membranes in high potassium media. J. Cell Biol.
99:1235-1241.
239. Aley, S.B., Z.A. Cohn, and W.A. Scott. 1984. Endocytosis
in Entamoeba histolytica. Evidence for a unique nonacidified compartment. J. Exp. Med. 160:724-737.
240. Cohn, Z.A. 1984. The macrophage in inflammation. In
Medicine, Science, and Society. K.J. Isselbacher, editor.
John Wiley & Sons, Inc., New York. 165-173.
241. Cohn, Z.A. 1984. Macrophages as multifaceted cells. Recent Adv. RES (Reticuloendothel. Syst.) Res. 24:17-24.
242. Cramer, E.B., G. Migliorisi, L. Pologe, E. Abrahams, N.A.
Pawlowski, Z. Cohn, and W.A. Scott. 1984. Effect of
leukotrienes on endothelium and the transendothelial migration of neutrophils. J. Allergy Clin. Immunol. 74:
386-390.
243. Horwitz, M.A., W.R. Levis, and Z.A. Cohn. 1984. Defective production of monocyte-activating cytokines in
lepromatous leprosy. J. Exp. Med. 159:666-678.
244. Kaplan, G., and Z.A. Cohn. 1984. Hansen's disease as
a research model. Bull. N Y Acad. Med. 60:712-721.
245. Nogueira, N., and Z.A. Cohn. 1984. Activation ofmononuclear phagocytes for the destruction ofintracellular parasites: studies with Trypanosoma cruzi. In Macrophage
Activation. Contemporary Topics in Immunobiology 13.
D.O. Adams and M.G. Hanna, editors. Plenum Publishing Corporation, New York. 117-126.
246. Pologe, L.G., E.B. Cramer, N.A. Pawlowski, E. Abraham, Z.A. Cohn, and W.A. Scott. 1984. Stimulation of
human endothelial cell prostacyclin synthesis by select
leukotrienes. J. Exp. Med. 160:1043-1053.
247. Sarno, E.N., G. Kaplan, F. Alvaranga, N. Nogueira, J.A.
Porto, and Z.A. Cohn. 1984. Effect of treatment on the
cellular composition of cutaneous lesions in leprosy patients. Int. J. Lepr. 52:496-500.
248. Scott, W.A., N.A. Pawlowski,J.T. Mills, and Z.A. Cohn.
1984. The metabolism of exogenous arachidonic acid
by resting macrophages. Adv. Inflammation Res. 7:39-49.

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

225.

tumor cells by sulfhydryl-reactive antineoplastics.J. Clin.
Invest. 71:258-267.
Cohn, Z.A. 1983. The macrophage--versatile element
of inflammation. In The Harvey Lectures, 1981-1982.
Series 77. Academic Press, New York. 63-80.
Cramer, E.B., L. Pologe, N.A. Pawlowski, Z.A. Cohn,
and W.A. Scott. 1983. Leukotriene C promotes prostacyclin synthesis by human endothelial cells. Proc. Natl.
Acad. Sci. USA. 80:4109-4113.
Kaplan, G., W.C. Van Voorhis, E.N. Sarno, N. Nogueira,
and Z.A. Cohn. 1983. The cutaneous infiltrates of leprosy. A transmission electron microscopy study. J. Exp.
Meal. 158:1145-1159.
Lepay, D.A., N. Nogueira, and Z. Cohn. 1983. Surface
antigens of Leishmania donovani promastigotes.J. Exp. Med.
157:1562-1572.
Mellman, I.S., H. Plutner, R.M. Steinman,J.C. Unkeless,
and Z.A. Cohn. 1983. Internalization and degradation
of macrophage Fc receptors during receptor-mediated
phagocytosis. J. Celt Biol. 96:887-895.
Muller, W.A., R.M. Steinman, and Z.A. Cohn. 1983.
Intracellular iodination oflysosome membrane for studies
of membrane composition and recycling. Methods Enzymol. 98:404-415.
Muller, W.A., R.M. Steinman, and Z.A. Cohn. 1983.
Membrane proteins of the vacuolar system. III. Further
studies on the composition and recycling of endocytic
vacuole membrane in cultured macrophages.J. Cell Biol.
96:29-36.
Nogueira, N., G. Kaplan, E. Levy, E.N. Sarno, P. Kushher, A. Granelli-Piperno, L. Vieira, V. Colomer-Gould,
W. Levis, R. Steinman, Y.K. Yip, and Z.A. Cohn. 1983.
Defective 3/interferon production in leprosy. Reversal
with antigen and interleukin 2. J. Exp. Med. 158:21652170.
Pawlowski, N.A., G. Kaplan, A.L. Hamill, Z.A. Cohn,
and W.A. Scott. 1983. Arachidonic acid metabolism by
human monocytes. Studies with platelet-depleted cultures.
J. Exp. Med. 158:393-412.
Scott, W.A., C.A. Rouzer, and Z.A. Cohn. 1983. Leukotriene C release by macrophages. Fed. Proc. 42:129-133.
Steinman, R.M., I.S. Mellman, W.A. Muller, and Z.A.
Cohn. 1983. Endocytosis and the recycling of plasma
membrane. J. Celt Biol. 96:1-27.
Van Voorhis, W.C., R.M. Steinman, L.S. Hair, J. Luban,
M.D. Witmer, S. Koide, and Z.A. Cohn. 1983. Specific
antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the
tissue localization of macrophages. J. Exp. Med. 158:
126-145.
Young, J.D.-E, G.P.H. Young, Z.A. Cohn, andJ. Lenard.
1983. Interaction of enveloped viruses with planar bilayer
membranes: observations on sendal, influenza, vesicular
stomatitis, and semliki forest viruses. Virology. 128:186194.
Young, J.D.-E, JIC. Unkeless, T.M. Young, A. Mauro,
and Z.A. Cohn. 1983. Role for mouse macrophage IgG

249. Young, G.EH.,J.D.-E Young, A.K. Deshpande, M. Goldstein, S.S. Koide, and Z.A. Cohn. 1984. A CaZ*-activated
channel from Xenopus laevis oocyte membranes reconstituted into planar bilayers. Proc. Natl. Acad. Sci. USA.
81:5155-5159.
250. Young, J.D.-E, S.S. Ko, and Z.A. Cohn. 1984. The increase in intracellular free calcium associated with IgG
T2b/~,l Fc receptor-ligand interactions: role in phagocytosis. Proc. Natl. Acad. Sci. USA. 81:5430-5434.

262.

263.

1985

26

Tributeto Zanvil Alexander Cohn

264.

265.

266.

267.

268.

269.

270,

1986

271. Aderem, A.A., D.S. Cohen, S.D. Wright, and Z.A. Cohn.
1986. Bacterial lipopolysaccharides prime macrophages
for enhanced release of arachidonic acid metabolites.
J. Exp. Mecl. 164:165-179.
272. Aderem, A.A., M.M. Keum, E. Pure, and Z.A. Cohn.
1986. Bacterial lipopolysaccharides, phorbol myristate acetate, and zymosan induce the myristoylation of specific
macrophage proteins. Proc. Natl. Acad. Sci. USA. 83:58175821.

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

251. Aderem, A.A., S.D. Wright, S.C. Silverstein, and Z.A.
Cohn. 1985. Ligated complement receptors do not activate the arachidonic acid cascade in resident peritoneal
macrophages. J. Exp. Med. 161:617-622.
252. Arrick, B.A., W. Griffo, Z. Cohn, and C. Nathan. 1985,
Hydrogen peroxide from cellular metabolism of cystine.
A requirement for lysis ofmurine tumor cells by vernolepin, a glutathione-depleting antineoplastic.J. Clin. Invest.
76:567-574.
253. Cohn, Z.A., and R.M. Steinman. 1985. The homogeneity and discreteness of membrane domains. In Mechanisms of Receptor Regulation. G. Poste and S.T. Crooke,
editors. Plenum Publishing Corporation, New York.
197-206.
254. Kaplan, G., D.E. Weinstein, R.M. Steinman, W.R. Levis,
U. Elvers, M.E. Patarroyo, and Z.A. Cohn. 1985. An
analysis of in vitro T cell responsiveness in lepromatous
leprosy..]. Exp. Med. 162:917-929.
255. Kaplan, G., and Z.A. Cohn. 1985. Cellular immunity
in lepromatous and tuberculoid leprosy. Immunol. Lett.
11:205-209.
256. Lepay, D.A., C.F. Nathan, R.M. Steinman, H.W. Murray,
and Z.A. Cohn. 1985. Murine Kupffer cells. Mononuclear phagocytes deficient in the generation of reactive oxygen intermediates. J. Exp. Med. 161:10791096.
257. Lepay, D.A., R.M. Steinman, C.F. Nathan, H.W. Murray, and Z.A. Cohn. 1985. Liver macrophages in murine
listeriosis. Cell-mediated immunity is correlated with an
influx ofmacrophages capable of generating reactive oxygen intermediates. J. Exp. Med. 161:1503-1512.
258. Nathan, C.E, and Z.A. Cohn. 1985. Cellular components
of inflammation: monocytes and macrophages. In Textbook ofRheumatology. 2nd Ed. W.N. Kelley, E.D. Harris,
Jr., S. Ruddy, and C.B. Sledge, editors. W.B. Saunders
Company, Philadelphia. 144--169.
259. Pawlowski, N.A., E.L. Abraham, S. Pontier, W.A. Scott,
and Z.A. Cohn. 1985. Human monocyte-endothelial cell
interaction in vitro. Proc. Natl. Acad. Sci. USA. 82:82088212.
260. Podack, E.R.,J.D.-E Young, and Z.A. Cohn. 1985. Isolation and biochemical and functional characterization
of perforin 1 from cytolytic T-cell granules. Proc. Natl.
Acad. Sci. USA. 82:8629-8633.
261. Scott, W.A., N.A. Pawlowski, E.B. Cramer, and Z.A.

Cohn. 1985. Secretory functions of the mononuclear
phagocyte. Adv. Exp. Med. Biol. 183:17-25.
Young, J.D.-E, and Z.A. Cohn. 1985. Molecular mechanisms of cytotoxicity mediated by Entamoeba histolytica:
characterization of a pore-forming protein (PFP).J. Cell.
Biochem. 29:299-308.
Young, J.D.-E, C.G.B. Peterson, P. Venge, and Z.A.
Cohn. 1985. How human eosinophil cationic protein
damages target membranes. In Inflammation: Basic Mechanisms, Tissue Injuring Principles, and Clinical Models.
P. Venge and A. Lindbom, editors. Almqvist & Wiksell
International, Stockholm. 351-357.
Young, J.D.-E,J.C. Unkeless, and Z.A. Cohn. 1985. Functional ion channel formation by mouse macrophage IgG
Fc receptor triggered by specific ligands.J. Cell. Biochem.
29:289-297.
Aderem, A.A., W.A. Scott, and Z.A. Cohn. 1985. Signalresponse coupling in the arachidonic acid cascade of
macrophages. In Mononuclear Phagocytes. Characteristics, Physiology and Function. R. van Furth, editor. Martinus Nijhoff, Dordrecht. 311-318.
Cohn, Z.A. 1985. Visions of the future. In Mononuclear
Phagocytes. Characteristics, Physiology and Function. R.
van Furth, editor. Martinus Nijhoff, Dordrecht. 821-823.
Kaplan, G., and Z.A. Cohn. 1985. Cell mediated immunity in lepromatous and tuberculoid leprosy. In Mononuclear Phagocytes. Charactefistcs, Physiology and Function. R. van Furth, editor. Martinus Nijhoff, Dordrecht.
631-643.
Lepay, D.A., R.M. Steinman, C.F. Nathan, H.W. Murray,
and Z.A. Cohn. 1985. Properties of resident and inflammatory macrophages in mouse liver. In Mononuclear Phagocytes. Characteristics, Physiology and Function. R. van
Furth, editor. Martinus Nijhoff, Dordrecht. 487-491.
Pawlowski, N.A., W.A. Scott, and Z.A. Cohn. 1985.
Human monocyte interaction with platelets and endothelial cells: synthesis of arachidonic acid metabolites. In
Mononuclear Phagocytes. Characteristics, Physiology and
Function. R. van Furth, editor. Martinus Nijhoff, Dordrecht. 733-746.
Young, J.D.-E, and Z.A. Cohn. 1985. Nature of transmembrane signal associated with binding to the macrophage IgG Fc receptor. In Mononuclear Phagocytes. Characteristics, Physiology and Function. R. van Furth, editor.
Martinus Nijhoff, Dordrecht. 399-407.

27

The Editors

288.

289.

290.

291.

292.
293.

294.

295.

296.

297.

298.

299.

Witmer, S.A. Sherwin, C.K. Job, C.R. Horowitz, R.M.
Steinman, and Z.A. Cohn. 1986. Local and systemic effects
ofintradermal recombinant interferon-y in patients with
lepromatous leprosy. N. Engl. J. Med. 315:6-15.
Young, J.D.-E, L.G. Leong, M.A. DiNome, and Z.A.
Cohn. 1986. A semiautomated hemolysis microassay for
membrane lytic proteins. Anal. Biochem. 154:649-654.
Young, J.D.-E, C.G.B. Peterson, P. Venge, and Z.A.
Cohn. 1986. Mechanism of membrane damage mediated
by human eosinophil cationic protein. Nature (Lond.). 321:
613-616.
Young, J.D.-E, C.F. Nathan, E.R. Podack, M.A. Palladino, and Z.A. Cohn. 1986. Functional channel formation associated with cytotoxic T-cell granules. Proc. Natl.
Acad. Sci. USA. 83:150--154.
Young, J.D.-E, H. Hengartner, E.R. Podack, and Z.A.
Cohn. 1986. Purification and characterization ofa cytolytic pore-forming protein from granules of cloned
lymphocytes with natural killer activity. Cell. 44:849-859.
Young, J.D.-E, and Z.A. Cohn. 1986. Cell-mediated killing: a common mechanism? Cell. 46:641-642.
Young, J.D.-E, A. Damiano, L.G. Leong, and Z.A. Cohn.
1986. Analysis of enzymatic activities of subcellular and
chromatographic fractions by an automated colorimetric
microassay system. Anal. Biochem. 158:28-35.
Young, J.D.-E, L.G. Leong, C.-C. Liu, A. Damiano, D.A.
Wall, and Z.A. Cohn. 1986. Isolation and characterization of a serine esterase from cytolytic T cell granules.
Cell. 47:183-194.
Young, J.D.-E, and Z.A. Cohn. 1986. Role of granule
proteins in lymphocyte-mediated killing.J. Cell. Biochem.
32:151-167.
Young, J.D.-E, Z.A. Cohn, and E.R. Podack. 1986. The
ninth component of complement and the pore-forming
protein (pefforin 1) from cytotoxic T cells: structural,
immunological, and functional similarities. Science (Wash.
DC). 233:184-190.
Young, J.D.-E, E.R. Podack, and Z.A. Cohn. 1986.
Properties of purified pore-forming protein (perforin 1)
isolated from H-2-restricted cytotoxic T cell granules.
J. Exp. Med. 164:144-155.
Young, J.D.-E, C.-C. Liu, L.G. Leong, and Z.A. Cohn.
1986. The pore-forming protein (perforin) ofcytolytic T
lymphocytes is immunologically related to the components
of membrane attack complex of complement through
cysteine-rich domains. J. Exp. Med. 164:2077-2082.
Young, J.D.-E, L.G. Leong, C.-C. Liu, A. Damiano, and
Z.A. Cobn. 1986. Extracellular release of lymphocyte
cytolytic pore-forming protein (perforin) after ionophore
stimulation. Proc. Natl. Acad. Sci. USA. 83:5668-5672.

1987

300. Cohn, Z.A. 1987. Macrophages: the first line of host defense. In Modem Biotechnology and Health: Perspectives
for the Year 2000. M.E. Patarroyo, J.B. Zabriskie, and D.
Pizano-Salazar, editors. Academic Press, New York. 41-50.

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

273. Aderem, A.A., W.A. Scott, and Z.A. Cohn. 1986. Evidence for sequential signals in the induction of the arachidonic acid cascade in macrophages. J. Exp. Med. 163:
139-154.
274. Aderem, A.A., and Z.A. Cohn. 1986. Bacterial lipopolysaccharides modify signal transduction in the arachidonic
acid cascade in macrophages. In Biochemistry of Macrophages. Ciba Foundation Symposium 118. D. Evered,
J. Nugent, and M. O'Connor, editors. Pitman Books Ltd.,
London. 196-210.
275. Cohn, Z.A. 1986. The first line ofdefence: introduction
and closing remarks. In Biochemistry of Macrophages.
Ciba Foundation Symposium 118. D. Evered,J. Nugent,
and M. O'Connor, editors. Pitman Books Ltd., London.
1-6; 242-243.
276. Cohn, Z.A., and G. Kaplan. 1986. Human leprosy: defects in cell-mediated immunity. In Mechanisms of Host
Resistance to Infectious Agents, Tumors, and Allografts.
R.M. Steinman and R.J. North, editors. The Rockefeller
University Press, New York. 285-304.
277. Fels, A.O.S., N.A. Pawlowski, E.L. Abraham, and Z.A.
Cohn. 1986. Compartmentalized regulation of macrophage arachidonic acid metabolism. J. Exp. Med. 163:
752-757.
278. Fels, A.O.S., and Z.A. Cohn. 1986. The alveolar macrophage. J. Appl. Physiol. 60:353-369.
279. Gabay, J.E., J.M. Heiple, Z.A. Cohn, and C.F. Nathan.
1986. Subcellular location and properties of bactericidal
factors from human neutrophils. J. Exp. Med. 164:14071421.
280. Gabay, J.E., M.A. Horwitz, and Z.A. Cohn. 1986.
Phagosome-lysosome fusion. Biochem. Soc. Trans. 14:256257.
281. Kaplan, G., and Z.A. Cohn. 1986. The immunobiology
of leprosy. Int. Rev. Exp. Pathol. 28:45-78.
282. Kaplan, G., and Z.A. Cohn. 1986. Regulation of cellmediated immunity in lepromatous leprosy. Lepr. Rev. 57:
199-202.
283. Kaplan, G., C.F. Nathan, R. Gandhi, M.A. Horwitz, W.R.
Levis, and Z.A. Cohn. 1986. Effect of recombinant interferon y on hydrogen peroxide-releasing capacity of
monocyte-derived macrophages from patients with lepromatous leprosy. J. Immunol. 137:983-987.
284. Kaplan, G., M.D. Witmer, I. Nath, R.M. Steinman,
S. Laal, H.K. Prasad, E.N. Sarno, U. Elvers, and Z.A.
Cohn. 1986. Influence of delayed immune reactions on
human epidermal keratinocytes. Proc. Natl. Acad. Sci.
USA. 83:3469-3473.
285. Liu, C.-C., B. Perussia, Z.A. Cohn, and J.D.-E Young.
1986. Identification and characterization of a pore-forming
protein of human peripheral blood natural killer cells.
J. Exp. Med. 164:2061-2076.
286. Montgomery, R.R., C.F. Nathan, and Z.A. Cohn. 1986.
Effects of reagent and cell-generated hydrogen peroxide
on the properties of low density lipoprotein. Proc. Natl.
Acad. Sci. USA. 83:6631-6635.
287. Nathan, C.F., G. Kaplan, W.R. Levis, A. Nusrat, M.D.

28

Tributeto Zanvil Alexander Cohn

erties of membrane lesions induced by human complement: polymerized C9 forms structural and functional
pores in lipid bilayers. In Perspectives in Inflammation,
Neoplasia and Vascular Cell Biology. T.S. Edgington,
R. Ross, and S.C. Silverstein, editors. Alan R. Liss, Inc.,
New York. 229-236.
315. Young, J.D.-E, and Z.A. Cohn. 1987. Characterization
of the cytolytic pore-forming protein of cytolytic T
lymphocyte granules. In Membrane-Mediated Cytotoxicity. B. Bonavida and R.J. Collier, editors. Alan R.
Liss, Inc., New York. 353-366.
316. Young, J.D.-E, W.R. Clark, C.-C. Liu, and Z.A. Cohn.
1987. A calcium- and perforin-independent pathway of
killing mediated by murine cytolytic lymphocytes.J. Exp.
Med. 166:1894-1899.
317. Young, J.D.-E, A. Damiano, M.A. DiNome, L.G.
Leong, and Z.A. Cohn. 1987. Dissociation of membrane binding and lytic activities of the lymphocyte
pore-forming protein (perforin).J. Exp. Med. 165:13711382.

1988

318. Aderem, A.A., K.A. Albert, M.M. Keum, J.K.T. Wang,
P. Greengard, and Z.A. Cohn. 1988. Stimulus-dependent
myristoylation of a major substrate for protein kinase C.
Nature (Lond.). 332:362-364.
319. Aderem, A.A., and Z.A. Cohn. 1988. Calcium ionophore
synergizes with bacterial lipopolysaccharides in activating macrophage arachidonic acid metabohsm.J. Exp. Med.
167:623-631.
320. Aderem, A.A., D.E. Marratta, and Z.A. Cohn. 1988.
Interferon 3' induces the myristoylation ofa 48-kDa protein in macrophages. Proc. Natl. Acad. Sci. USA. 85:63106313.
321. Aderem, A.A., and Z.A. Cohn. 1988. Modulation of
macrophage arachidonic acid metabolism by bacterial hpoplysaccharides (sic); the role of protein myristoylation and
calcium transients. In Bacteria-Host Cell Interactions.
M.A. Horwitz, editor. Alan R. Liss, Inc., New York.
141-156.
322. Cohn, Z.A., and R.M. Steinman. 1988. The immunological and infectious sequelae of the acquired immune
deficiency syndrome. J. Exp. Med. 168:2415-2423.
323. Cohn, Z.A. 1988. Innate immunity. Overview. Curr.
Opin. lmmunol. 1:3-4.
324. Hancock, G.E., G. Kaplan, and Z.A. Cohn. 1988. Keratinocyte growth regulation by the products of immune
cells. J. Exp. Med. 168:1395-1402.
325. Kaplan, G., S. Laal, G. Sheftel, A. Nusrat, I. Nath, N.K.
Mathur, R.S. Mishra, and Z.A. Cohn. 1988. The nature
and kinetics of a delayed immune response to purified
protein derivative of tuberculin in the skin oflepromatous
leprosy patients. J. Exp. Med. 168:1811-1824.
326. Kaplan, G., G. Sheftel, C.K.Job, N.K. Mathur, I. Nath,
and Z.A. Cohn. 1988. Efficacy of a cell-mediated reaction to purified protein derivative of tuberculin in the

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

301. Detmers, P.A., S.D. Wright, E. Olsen, B. Kimball, and
Z.A. Cohn. 1987. Aggregation of complement receptors
on human neutrophils in the absence of ligand. J. Cell
Biol. 105:1137-1145.
302. Fels, A.O.S., C.F. Nathan, and Z.A. Cohn. 1987. Hydrogen peroxide release by alveolar macrophages from sarcoid patients and by alveolar macrophages from normals
after exposure to recombinant interferons teA,/3, and 3'
and 1,25-dihydroxyvitamin D3. J. Clin. Invest. 80:381386.
303. Kaplan, G., R.R. Gandhi, D.E. Weinstein, W.R. Levis,
M.E. Patarroyo, p.J. Brennan, and Z.A. Cohn. 1987. Mycobacterium lepraeantigen-induced suppression o f T cell proliferation in vitro._]. Immunol. 138:3028-3034.
304. Kaplan, G., A. Nusrat, E.N. Sarno, C.K. Job, J. McE1rath, J.A. Porto, C.F. Nathan, and Z.A. Cohn. 1987.
Cellular responses to the intradermal injection of recombinant human 3,-interferon in lepromatous leprosy
patients. Am.J. Pathol. 128:345-353.
305. Kaplan, G., A. Nusrat, M.D. Witmer, I. Nath, and Z.A.
Cohn. 1987. Distribution and turnover of Langerhans cells
during delayed immune responses in human skin.J. Exp.
Med. 165:763-776.
306. Kaplan, G., A.D. Luster, G. Hancock, and Z.A. Cohn.
1987. The expression of a 3' interferon-induced protein
(IP-10) in delayed immune responses in human skin.
J. Exp. Med. 166:1098-1108.
307. McElrath, M.J., G. Kaplan, A. Nusrat, and Z.A. Cohn.
1987. Cutaneous leishmaniasis. The defect in T cell influx
in BALB/c mice. J. Exp. Med. 165:546-559.
308. McElrath, M.J., H.W. Murray, and Z.A. Cohn. 1987. The
local cellular immune response in experimental leishmaniasis. Ann. Inst. Pasteur Immunol. 138:787-795.
309. Young, J.D.-E, and Z.A. Cohn. 1987. Cellular and humoral mechanisms of cytotoxicity: structural and functional analogies. Adv. Immunol. 41:269-332.
310. Young, J.D.-E, C.-C. Liu, L.G. Leong, A. Damiano, EM.
Persechini, and Z.A. Cohn. 1987. An automated colorimetric microassay system for rapid and quantitative determination of soluble enzymatic activities. BioTechniques.
5:572-576.
311. Young, J.D.-E, Z.A. Cohn, and N.B. Gilula. 1987. Functional assembly of gap junction conductance in lipid bilayers: demonstration that the major 27 kd protein forms
the junctional channel. Cell. 48:733-743.
312. Young, J.D.-E, C.-C. Liu, G. Butler, Z.A. Cohn, and
S.J. Galli. 1987. Identification, purification, and characterization of a mast cell-associated cytolytic factor related
to tumor necrosis factor. Proc. Natl. Acad. Sci. USA. 84:
9175-9179.
313. Young, J.D.-E, C.E Nathan, M.A. Palladino, and Z.A.
Cohn. 1987. Interaction ofcytotoxic T cells with target
membranes: evidence for pore formation. In Perspectives
in Inflammation, Neoplasia and Vascular Cell Biology.
T.S. Edgington, R. Ross, and S.C. Silverstein, editors.
Alan R. Liss, Inc., New York. 247-253.
314. Young, J.D.-E, Z.A. Cohn, and E.R. Podack. 1987. Prop-

327.

328.

329.

330.

332.

333.

334.
335.

1989

336. Hancock, G.E., Z.A. Cohn, and G. Kaplan. 1989. The
generation of antigen-specific, major histocompatibility
complex-restricted cytotoxic T lymphocytes of the CD4 +
phenotype. Enhancement by the cutaneous administration of interleukin 2. J. Exp. Med. 169:909-919.
337. Kaplan, G., E.P. Sampaio, G.P. Walsh, R.A. Burkhardt,
T.T. Fajardo, L.S. Guido, A. de Miranda Machado, R.V.
Cellona, R.M. Abalos, E.N. Sarno, and Z.A. Cohn. 1989.
Influence ofMycobacterium leprae and its soluble products
on the cutaneous responsiveness of leprosy patients to
antigen and recombinant interleukin 2. Proc. Natl. Acad.
Sci. USA. 86:6269-6273.
338. Kaplan, G., R. Kiessling, S. Teklemariam, G. Hancock,
G. Sheftel, C.K. Job, P. Converse, T.H.M. Ottenhoff,
M. Becx-Bleumink, M. Dietz, and Z.A. Cohn. 1989.
The reconstitution of cell-mediated immunity in the cuta29

The Editors

339.

340.

341.

342.

343.

344.

345.

neous lesions oflepromatous leprosy by recombinant interleukin 2. J. Exp. Med. 169:893-907.
Kaplan, G., N.K. Mathur, C.K. Job, I. Nath, and Z.A.
Cohn. 1989. Effect of multiple interferon 3' injections
on the disposal of Mycobacterium leprae. Proc. Natl. Acad.
Sci. USA. 86:8073-8077.
Langhoff, E.,J. McElrath, H.J. Bos, J. Pruett, A. GranelliPiperno, Z.A. Cohn, and R.M. Steinman. 1989. Most
CD4 + T cells from human immunodeficiency virus-1
infected patients can undergo prolonged clonal expansion.
J. Clin. Invest. 84:1637-1643.
McElrath, M.J.,J.E. Pruett, and Z.A. Cohn. 1989. Mononuclear phagocytes of blood and bone marrow: Comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc. Natl. Acad. Sci. USA.
86: 675-679.
McElrath, M.J., H.W. Murray, and Z.A. Cohn. 1989. The
local T cell response in experimental leishmaniasis. In
Leishmaniasis. The Current Status and New Strategies
for Control. D.T. Hart, editor. Plenum Publishing Corporation, New York. 325-328.
Montgomery, R.R., and Z.A. Cohn. 1989. Endocytic and
secretory repertoire of the lipid-loaded macrophage.
J. Leukocyte Biol. 45:129-138.
Muller, W.A., C.M. Ratti, S.L. McDonnell, and Z.A.
Cohn. 1989. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J. Exp. Med. 170:399-414.
Rosen, A., A.C. Nairn, P. Greengard, Z.A. Cohn, and
A. Aderem. 1989. Bacterial lipopolysaccharide regulates
the phosphorylation of the 68K protein kinase C substrate
in macrophages. J. Biol. Chem. 264:9118-9121.

1990

346. Moberg, C.L., and Z.A. Cohn, editors. 1990. Launching
the Antibiotic Era. The Rockefeller University Press, New
York. 97 pp.
347. Akuffo, H., G. Kaplan, R. Kiessling, S. Teklemariam,
M. Dietz, J. McElrath, and Z.A. Cohn. 1990. Administration of recombinant interleukin-2 reduces the local
parasite load of patients with disseminated cutaneous leishmaniasis. J. Infect. Dis. 161:775-780.
348. Converse, P., T.H.M. Ottenhoff, S.W. Teklemariam,
G.E. Hancock, M. Dietz, M. Becx-Bleumink, A.
Wondimu, R. Kiessling, Z.A. Cohn, and G. Kaplan. 1990.
Intradermal recombinant interleukin 2 enhances peripheral blood T-cell responses to mitogen and antigens in
patients with lepromatous leprosy. Scand.J. Immunol. 32:
83-91.
349. Detmers, P.A., S.K. Lo, E. Olsen-Egbert, A. Walz, M.
Baggiolini, and Z.A. Cohn. 1990. Neutrophil-activating
protein 1/interleukin 8 stimulates the binding activity
of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J. Exp. Med. 171:1155-1162.
350. McElrath, M.J., G. Kaplan, R.A. Burkhardt, and Z.A.
Cohn. 1990. Cutaneous response to recombinant inter-

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

331.

disposal of Mycobacterium leprae from human skin. Proc.
Natl. Acad. Sci. USA 85:5210-5214.
McElrath, M.J., H.W. Murray, and Z.A. Cohn. 1988. The
dynamics ofgranuloma formation in experimental visceral
leishmaniasis. J. Exp. Med. 167:1927-1937.
Nusrat, A.R., S.D. Wright, A.A. Aderem, R.M. Steinman, and Z.A. Cohn. 1988. Properties of isolated red
pulp macrophages from mouse spleen.J. Exp. Med. 168:
1505-1510.
Pawlowski, N.A., G. Kaplan, E. Abraham, and Z.A.
Cohn. 1988. The selective binding and transmigration
of monocytes through the junctional complexes of human endothelium. J. Exp. Med. 168:1865-1882.
Young, J.D.-E, Z.A. Cohn, and E.R. Podack. 1988.
Pore size and functional properties of defined mac and
poly C9 complexes: reconstitution into model lipid
membranes. In Cytolytic Lymphocytes and Complement.
E.R. Podack, editor. CRC Press, Boca Raton, FL. 221227.
Young, J.D.-E, E.R. Podack, C.F. Nathan, H. Hengartner, and Z.A. Cohn. 1988. Properties oftransmembrane
channels induced by cytolytic lymphocytes. In Cytolytic
Lymphocytes and Complement. E.R. Podack, editor.
CRC Press Inc., Boca Raton, FL. 19-33.
Young, J.D.-E, C.-C. Liu, L.G. Leong, A. Damiano, M.A.
DiNome, and Z.A. Cohn. 1988. Cytolytic pore-forming
proteins. In Leukolysins and Cancer. J.H. Ransom and
J.R. Ortaldo, editors. Humana Press Inc., Clifton, NJ.
9-43.
Young, J.D.-E, C.-C. Liu, P.M. Persechini, and Z.A.
Cohn. 1988. Perforin-dependent and -independent pathways ofcytotoxicity mediated by lymphocytes. Immunol.
Rev. 103:161-202.
Young, J.D.-E, and Z.A. Cohn. 1988. How killer cells
kill. Sci. Am. 258:38-44.
Young, J.D.-E, and Z.A. Cohn. 1988. Molecular basis
of lymphocyte-mediated destruction of target cells. News
Physiol. Sci. 3:211-216.

leukin 2 in human immunodeficiency virus 1-seropositive
individuals. Proc. Natl. Acad. Sci. USA. 87:5783-5787.
351. Molloy, A., G. Gaudernack, W.R. Levis, Z.A. Cohn,
and G. Kaplan. 1990. Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of
lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 87:973977.

1991

30

Tributeto Zanvil Alexander Cohn

1993

367. Kaplan, G., and Z.A. Cohn. 1993. Effects ofintradermal
recombinant human granulocyte-macrophage colonystimulating factor on Langerhans cell recruitment and
keratinocyte growth. In Hemopoietic Growth Factors
and Mononuclear Phagocytes. R. van Furth, editor.
S. Karger AG, Basel. 205-210.
368. Schauf, V., W.N. Rom, K.A. Smith, E.P. Sampaio, P.A.
Meyn, J.M. Tramontana, Z.A. Cohn, and G. Kaplan.
1993. Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients.
J. Infect. Dis. 168:1056-1059.
369. Teppler, H., G. Kaplan, K.A. Smith, A.L. Montana, P.
Meyn, and Z.A. Cohn. 1993. Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin
2 in patients with human immunodeficiency virus type
1 infection. J. Exp. Med. 177:483-492.
370. Teppler, H., G. Kaplan, K. Smith, P. Cameron, A. Montana, P. Meyn, and Z. Cohn. 1993. Efficacy of low doses
of the polyethylene glycol derivative ofinterleukin-2 in
modulating the immune response of patients with human immunodeficiency virus type 1 infection. J. Infect.
Dis. 167:291-298.

Downloaded from https://rupress.org/jem/article-pdf/179/1/1/495290/1.pdf by Rockefeller University user on 28 July 2020

352. Cohn, Z.A., and G. Kaplan. 1991. Hansen's disease, cellmediated immunity, and recombinant lymphokines.
J. Infect. Dis. 163:1195-1200.
353. Cohn, Z.A., and C.L. Moberg. 1991. James G. Hirsch:
1922-1987. Transactions of the Association of American
Physicians. CIV:cxxiii-cxxv.
354. Detmers, P.A., D.E. Powell, A. Walz, I. Clark-Lewis,
M. Baggiolini, and Z.A. Cohn. 1991. Differential effects
of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis.J. Immunol. 147:4211-4217.
355. Hancock, G.E., A. Molloy, B.K. Ab, R. Kiessling, M.
Becx-Bleumink, Z.A. Cohn, and G. Kaplan. 1991. In
vivo administration of low-dose human interleukin-2
induces lymphokine-activated killer cells for enhanced
cytolysis in vitro. Cell. Immunol. 132:277-284.
356. Kaplan, G., and Z.A. Cohn. 1991. Leprosy and cellmediated immunity. Curr. Opin. Immunol. 3:91-96.
357. Kaplan, G., W.J. Britton, G.E. Hancock, W.J. Theuvenet,
K.A. Smith, C.K. Job, P.W. Roche, A. Molloy, R. Burkhardt, J. Barker, H.M. Pradhan, and Z.A. Cohn. 1991.
The systemic influence of recombinant interleukin 2 on
the manifestations of lepromatous leprosy. J. Exp. Med.
173:993-1006.
358. McElrath, M.J., R.M. Steinman, and Z.A. Cohn. 1991.
Latent HIV-1 infection in enriched populations of blood
monocytes and T cells from seropositive patients.J. Clin.
Invest. 87:27-30.
359. Moberg, C.L., and Z.A. Cohn. 1991. RenrJules Dubos.
This quintessential environmentalist's quest for mechanisms of disease evolved into a philosopher's search for
health. Sci. Am. 264:66-74.
360. Ojcius, D.M., Z.A. Cohn, and J.D.-E Young. 1991.
Lymphocyte-mediated cytotoxicity. In Encyclopedia of
Human Biology. Vol. 4. Academic Press, New York. 811817.
361. Sampaio, E.P., E.N. Sarno, R. Galilly, Z.A. Cohn, and
G. Kaplan. 1991. Thalidomide selectively inhibits tumor
necrosis factor ~ production by stimulated human monocytes. J. Exp. Meal. 173:699-703.

1992

362. Cohn, Z.A. 1992. The enhancement of cell-mediated
immunity with recombinant lymphokines: studies in
leprosy and AIDS. In Immunology in the 21st Century.
F.W. Alt, editor. Sigma Chemical Co., St. Louis. 109-126.
363. Cohn, Z.A., and G. Kaplan. 1992. Leprosy--Hansen's
disease. In Cecil Textbook of Medicine. 19th Ed. J.B.
Wyngaarden, L.H. Smith, Jr., andJ.C. Bennett, editors.
W.B. Saunders Company, Philadelphia. 1745-1751.
364. Kaplan, G., G. Walsh, L.S. Guido, P. Meyn, R.A. Burkhardt, R.M. Abalos, J. Barker, P.A. Frindt, T.T. Fajardo,
R. Celona, and Z.A. Cohn. 1992. Novel responses of
human skin to intraderrnal recombinant granulocyte/
macrophage-colony-stimulating factor: Langerhans cell
recruitment, keratinocyte growth, and enhanced wound
healing. J. Exp. Med. 175:1717-1728.
365. Kaplan, G., Z.A. Cohn, and K.A. Smith. 1992. Rational
immunotherapy with interleukin 2. Bio/Technology. 10:
157-162.
366. Kaplan, G., and Z.A. Cohn. 1992. Leprosy a model for
cell-mediated immunity: the effects and consequences
of recombinant lymphokine immunotherapy. In Mononuclear Phagocytes. Biology of Monocytes and Macrophages. R. van Furth, editor. Kluwer Academic Publishers,
Dordrecht. 644-648.

